Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7b-5p ABL1 -0.23 0.93895 0.02 0.9921 miRNAWalker2 validate -0.1 0.00372 NA
2 hsa-miR-128-3p ABL1 -0.44 0.78389 0.02 0.9921 MirTarget -0.12 0.00042 NA
3 hsa-let-7d-5p ABL2 -0.14 0.93416 0.26 0.81476 miRNATAP -0.17 0.00193 NA
4 hsa-let-7g-5p ABL2 -0.2 0.92299 0.26 0.81476 miRNATAP -0.18 0.00066 NA
5 hsa-miR-106b-5p ABL2 -0.3 0.86929 0.26 0.81476 MirTarget -0.15 5.0E-5 NA
6 hsa-miR-107 ABL2 -0.04 0.98836 0.26 0.81476 MirTarget; PITA; miRanda; miRNATAP -0.15 0.0065 NA
7 hsa-miR-1266-5p ABL2 -0.75 0.4758 0.26 0.81476 MirTarget -0.13 0 NA
8 hsa-miR-128-3p ABL2 -0.44 0.78389 0.26 0.81476 MirTarget -0.2 0 NA
9 hsa-miR-141-3p ABL2 -0.32 0.87774 0.26 0.81476 MirTarget; TargetScan; miRNATAP -0.13 0 NA
10 hsa-miR-141-5p ABL2 -0.35 0.86764 0.26 0.81476 MirTarget; miRNATAP -0.15 0 NA
11 hsa-miR-146a-5p ABL2 -0.58 0.73685 0.26 0.81476 MirTarget; mirMAP -0.13 1.0E-5 NA
12 hsa-miR-148a-5p ABL2 -0.45 0.74842 0.26 0.81476 miRNATAP -0.15 0 NA
13 hsa-miR-155-5p ABL2 -0.41 0.82867 0.26 0.81476 mirMAP -0.11 0.00074 NA
14 hsa-miR-15a-5p ABL2 -0.07 0.96484 0.26 0.81476 MirTarget; miRNATAP -0.16 5.0E-5 NA
15 hsa-miR-15b-3p ABL2 -0.56 0.60918 0.26 0.81476 mirMAP -0.14 4.0E-5 NA
16 hsa-miR-15b-5p ABL2 -0.27 0.87097 0.26 0.81476 MirTarget; miRNATAP -0.12 0.00091 NA
17 hsa-miR-16-5p ABL2 0.01 0.99448 0.26 0.81476 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00034 NA
18 hsa-miR-186-5p ABL2 -0.32 0.85413 0.26 0.81476 MirTarget; mirMAP -0.21 1.0E-5 NA
19 hsa-miR-200a-3p ABL2 -0.37 0.85106 0.26 0.81476 MirTarget; miRNATAP -0.13 0 NA
20 hsa-miR-200a-5p ABL2 -0.67 0.78126 0.26 0.81476 mirMAP -0.19 0 NA
21 hsa-miR-200b-3p ABL2 -0.43 0.86396 0.26 0.81476 MirTarget -0.15 0 NA
22 hsa-miR-200b-5p ABL2 -0.5 0.72226 0.26 0.81476 mirMAP -0.16 0 NA
23 hsa-miR-200c-3p ABL2 -0.44 0.88712 0.26 0.81476 MirTarget -0.13 7.0E-5 NA
24 hsa-miR-26a-1-3p ABL2 -0.43 0.18214 0.26 0.81476 MirTarget; mirMAP -0.11 7.0E-5 NA
25 hsa-miR-26b-5p ABL2 -0.02 0.99038 0.26 0.81476 MirTarget; miRNATAP -0.15 0.00106 NA
26 hsa-miR-324-5p ABL2 -0.5 0.53742 0.26 0.81476 miRNATAP -0.11 0.0015 NA
27 hsa-miR-378a-3p ABL2 -0.47 0.79506 0.26 0.81476 mirMAP -0.15 8.0E-5 NA
28 hsa-miR-429 ABL2 -0.46 0.80624 0.26 0.81476 MirTarget -0.12 0 NA
29 hsa-miR-505-3p ABL2 -0.47 0.69038 0.26 0.81476 miRNATAP -0.1 0.00934 NA
30 hsa-miR-576-5p ABL2 -0.51 0.41719 0.26 0.81476 mirMAP -0.15 0 NA
31 hsa-miR-582-3p ABL2 -0.23 0.89768 0.26 0.81476 PITA -0.16 1.0E-5 NA
32 hsa-miR-589-5p ABL2 -0.45 0.72273 0.26 0.81476 MirTarget; miRNATAP -0.16 0.00035 NA
33 hsa-miR-590-3p ABL2 -0.28 0.59127 0.26 0.81476 PITA; mirMAP; miRNATAP -0.13 0 NA
34 hsa-miR-625-3p ABL2 -0.98 0.62433 0.26 0.81476 mirMAP -0.15 0 NA
35 hsa-miR-7-1-3p ABL2 -0.46 0.6659 0.26 0.81476 mirMAP -0.13 5.0E-5 NA
36 hsa-miR-744-3p ABL2 -0.54 0.49055 0.26 0.81476 mirMAP -0.11 0.00025 NA
37 hsa-miR-93-5p ABL2 -0.61 0.8253 0.26 0.81476 MirTarget -0.15 3.0E-5 NA
38 hsa-miR-106a-5p AKT3 -0.2 0.80221 0.46 0.53933 miRNATAP -0.55 0 NA
39 hsa-miR-106b-5p AKT3 -0.3 0.86929 0.46 0.53933 miRNATAP -0.91 0 NA
40 hsa-miR-107 AKT3 -0.04 0.98836 0.46 0.53933 PITA; miRanda -0.55 0.00017 NA
41 hsa-miR-1275 AKT3 -0.83 0.08038 0.46 0.53933 PITA -0.27 0 NA
42 hsa-miR-142-3p AKT3 -0.15 0.9461 0.46 0.53933 miRanda -0.2 0.00627 NA
43 hsa-miR-15a-5p AKT3 -0.07 0.96484 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
44 hsa-miR-15b-5p AKT3 -0.27 0.87097 0.46 0.53933 miRNATAP -0.67 0 NA
45 hsa-miR-16-5p AKT3 0.01 0.99448 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
46 hsa-miR-17-3p AKT3 0.1 0.96011 0.46 0.53933 miRNATAP -0.52 0 NA
47 hsa-miR-17-5p AKT3 -0.18 0.93454 0.46 0.53933 TargetScan; miRNATAP -0.63 0 NA
48 hsa-miR-181b-5p AKT3 0.16 0.93018 0.46 0.53933 miRNATAP -0.27 0.00963 NA
49 hsa-miR-20a-5p AKT3 -0.18 0.92812 0.46 0.53933 miRNATAP -0.53 0 NA
50 hsa-miR-28-3p AKT3 -0.23 0.93535 0.46 0.53933 miRNATAP -0.52 0.00719 NA
51 hsa-miR-29a-3p AKT3 0.01 0.99698 0.46 0.53933 miRNATAP -0.81 0 NA
52 hsa-miR-29b-3p AKT3 -0.1 0.95899 0.46 0.53933 miRNATAP -0.68 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
53 hsa-miR-32-3p AKT3 -0.57 0.13133 0.46 0.53933 mirMAP -0.56 0 NA
54 hsa-miR-320a AKT3 -0.42 0.8402 0.46 0.53933 PITA; miRanda; miRNATAP -0.33 0.00138 NA
55 hsa-miR-320b AKT3 -0.24 0.85922 0.46 0.53933 PITA; miRanda; miRNATAP -0.25 0.00855 NA
56 hsa-miR-335-3p AKT3 -0.24 0.8845 0.46 0.53933 mirMAP -0.58 0 NA
57 hsa-miR-33a-3p AKT3 -0.79 0.01052 0.46 0.53933 mirMAP -0.49 0 NA
58 hsa-miR-340-5p AKT3 -0 0.99757 0.46 0.53933 mirMAP -0.28 0.006 NA
59 hsa-miR-362-3p AKT3 -0.72 0.03459 0.46 0.53933 miRanda -0.42 0 NA
60 hsa-miR-362-5p AKT3 -0.27 0.75202 0.46 0.53933 PITA; TargetScan; miRNATAP -0.52 0 NA
61 hsa-miR-369-3p AKT3 0.12 0.8323 0.46 0.53933 mirMAP -0.23 0.00901 NA
62 hsa-miR-374a-5p AKT3 -0.34 0.76692 0.46 0.53933 mirMAP -0.58 0 NA
63 hsa-miR-374b-5p AKT3 -0.29 0.8357 0.46 0.53933 mirMAP -0.68 0 NA
64 hsa-miR-421 AKT3 -0.18 0.7347 0.46 0.53933 miRanda; mirMAP -0.46 0 NA
65 hsa-miR-424-5p AKT3 0.25 0.87015 0.46 0.53933 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
66 hsa-miR-501-3p AKT3 -0.75 0.55276 0.46 0.53933 miRNATAP -0.5 0 NA
67 hsa-miR-502-3p AKT3 -0.48 0.5143 0.46 0.53933 miRNATAP -0.64 0 NA
68 hsa-miR-502-5p AKT3 -0.71 0.02613 0.46 0.53933 PITA; miRNATAP -0.41 0 NA
69 hsa-miR-505-3p AKT3 -0.47 0.69038 0.46 0.53933 mirMAP -0.77 0 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
70 hsa-miR-548o-3p AKT3 -0.19 0.51773 0.46 0.53933 mirMAP -0.31 8.0E-5 NA
71 hsa-miR-577 AKT3 -1.06 0.32606 0.46 0.53933 mirMAP -0.38 0 NA
72 hsa-miR-663b AKT3 0.1 0.81499 0.46 0.53933 PITA -0.25 1.0E-5 NA
73 hsa-miR-769-5p AKT3 -0.31 0.7357 0.46 0.53933 PITA; miRNATAP -0.84 0 NA
74 hsa-miR-93-5p AKT3 -0.61 0.8253 0.46 0.53933 miRNATAP -0.76 0 NA
75 hsa-miR-335-3p ANGPT1 -0.24 0.8845 0.1 0.80536 mirMAP -0.38 0 NA
76 hsa-miR-338-5p ANGPT1 0.48 0.39396 0.1 0.80536 PITA; miRNATAP -0.18 0.00519 NA
77 hsa-miR-429 ANGPT1 -0.46 0.80624 0.1 0.80536 miRanda -0.54 0 NA
78 hsa-miR-486-5p ANGPT1 -0.55 0.6964 0.1 0.80536 miRanda -0.16 0.0065 NA
79 hsa-miR-590-3p ANGPT1 -0.28 0.59127 0.1 0.80536 PITA; miRanda; mirMAP -0.61 0 NA
80 hsa-miR-135b-5p ANGPT2 0.63 0.61003 0.31 0.67026 MirTarget -0.11 0.00266 NA
81 hsa-miR-142-5p ANGPT2 -0.12 0.92967 0.31 0.67026 MirTarget -0.15 0.00359 NA
82 hsa-miR-374b-5p ANGPT2 -0.29 0.8357 0.31 0.67026 mirMAP -0.27 0.00081 NA
83 hsa-miR-429 ANGPT2 -0.46 0.80624 0.31 0.67026 miRanda -0.16 0.00035 NA
84 hsa-miR-491-3p ANGPT2 -0.51 0.13784 0.31 0.67026 MirTarget; miRNATAP -0.16 0.00076 NA
85 hsa-miR-590-3p ANGPT2 -0.28 0.59127 0.31 0.67026 miRanda -0.16 0.0007 NA
86 hsa-miR-181c-5p ARF6 0.04 0.96916 -0.14 0.93636 MirTarget -0.18 0 NA
87 hsa-miR-181d-5p ARF6 0.15 0.888 -0.14 0.93636 MirTarget -0.13 0 NA
88 hsa-miR-199a-5p ARF6 0.16 0.9358 -0.14 0.93636 MirTarget; PITA; miRanda; miRNATAP -0.12 0.00085 NA
89 hsa-miR-217 ARF6 0.34 0.761 -0.14 0.93636 miRanda -0.11 0 NA
90 hsa-miR-218-5p ARF6 0.23 0.81021 -0.14 0.93636 MirTarget -0.11 0.00035 NA
91 hsa-miR-23a-3p ARF6 -0.12 0.96272 -0.14 0.93636 MirTarget -0.16 0.00688 NA
92 hsa-let-7a-5p BCL2L1 -0.06 0.98501 0.24 0.89096 TargetScan; miRNATAP -0.27 0.0015 26915294; 20347499 As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;The let 7 family of microRNAs inhibits Bcl xL expression and potentiates sorafenib induced apoptosis in human hepatocellular carcinoma; The effect of let-7 on Bcl-xL expression was examined by Western blot and a reporter assay; Microarray analysis followed by in silico target prediction identified let-7 microRNAs as being downregulated in Huh7 hepatoma cells in comparison with primary human hepatocytes as well as possessing a putative target site in the bcl-xl mRNA
93 hsa-let-7a-3p BDNF -0.22 0.85543 0.5 0.16933 MirTarget; miRNATAP -0.24 0.00935 NA
94 hsa-miR-15a-5p BDNF -0.07 0.96484 0.5 0.16933 MirTarget; miRNATAP -0.36 0.00046 26581909 MicroRNA 15a 5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF; BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation; MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells; Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro; Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC
95 hsa-miR-15b-5p BDNF -0.27 0.87097 0.5 0.16933 MirTarget; miRNATAP -0.32 0.00075 NA
96 hsa-miR-16-5p BDNF 0.01 0.99448 0.5 0.16933 MirTarget; miRNATAP -0.34 0.00032 NA
97 hsa-miR-191-5p BDNF -0.48 0.81535 0.5 0.16933 miRNATAP -0.33 0.00023 NA
98 hsa-miR-210-3p BDNF -0.53 0.78221 0.5 0.16933 miRNAWalker2 validate; miRTarBase -0.18 0.0001 NA
99 hsa-miR-26b-3p BDNF -0.36 0.68112 0.5 0.16933 MirTarget -0.27 0.00219 NA
100 hsa-miR-29b-1-5p BDNF -0.64 0.29389 0.5 0.16933 mirMAP -0.21 0.00039 NA
101 hsa-miR-30b-5p BDNF -0.01 0.99462 0.5 0.16933 miRNATAP -0.26 0.00173 NA
102 hsa-miR-32-3p BDNF -0.57 0.13133 0.5 0.16933 miRNATAP -0.29 0 NA
103 hsa-miR-339-5p BDNF -0.3 0.71291 0.5 0.16933 miRanda -0.26 0.00013 NA
104 hsa-miR-33a-3p BDNF -0.79 0.01052 0.5 0.16933 mirMAP -0.19 0.00849 NA
105 hsa-miR-452-3p BDNF -0.17 0.79901 0.5 0.16933 MirTarget -0.17 0.00525 NA
106 hsa-miR-577 BDNF -1.06 0.32606 0.5 0.16933 mirMAP; miRNATAP -0.18 4.0E-5 NA
107 hsa-miR-589-3p BDNF -0.84 0.0112 0.5 0.16933 MirTarget -0.29 1.0E-5 NA
108 hsa-miR-589-5p BDNF -0.45 0.72273 0.5 0.16933 miRNATAP -0.38 0.00124 NA
109 hsa-miR-590-3p BDNF -0.28 0.59127 0.5 0.16933 miRanda; mirMAP; miRNATAP -0.32 0 NA
110 hsa-miR-7-1-3p BDNF -0.46 0.6659 0.5 0.16933 MirTarget -0.34 4.0E-5 NA
111 hsa-miR-30a-5p BRAP 0.22 0.93395 -0.11 0.91983 miRNATAP -0.1 0.00136 NA
112 hsa-miR-181c-5p CALM1 0.04 0.96916 -0.19 0.92562 miRNATAP -0.1 0.00012 NA
113 hsa-miR-664a-3p CALM1 -0 0.99612 -0.19 0.92562 mirMAP -0.1 0.00153 NA
114 hsa-miR-130a-3p CALM2 0.09 0.9291 0 0.99875 miRNATAP -0.12 5.0E-5 NA
115 hsa-miR-199a-5p CALM2 0.16 0.9358 0 0.99875 miRanda -0.11 0.00051 NA
116 hsa-miR-143-5p CDC42 0.11 0.93336 -0.15 0.93702 miRNATAP -0.12 2.0E-5 NA
117 hsa-miR-23b-3p CHUK -0.11 0.96135 -0.1 0.93218 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.14 0.00997 NA
118 hsa-miR-106a-5p CSF1 -0.2 0.80221 -0.25 0.7772 miRNATAP -0.32 0 NA
119 hsa-miR-106b-5p CSF1 -0.3 0.86929 -0.25 0.7772 miRNATAP -0.61 0 NA
120 hsa-miR-128-3p CSF1 -0.44 0.78389 -0.25 0.7772 MirTarget -0.26 0.00496 22909061 By mutations in putative miRNA targets in CSF-1 mRNA 3'UTR we identified a common target for both miR-128 and miR-152; We have also found that both miR-128 and miR-152 down-regulate CSF-1 mRNA and protein expression in ovarian cancer cells leading to decreased cell motility and adhesion in vitro two major aspects of the metastatic potential of cancer cells; Our results provide the evidence for a mechanism by which miR-128 and miR-152 down-regulate CSF-1 an important regulator of ovarian cancer
121 hsa-miR-130b-3p CSF1 -0.22 0.82466 -0.25 0.7772 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.47 0 22005523 CSF-1 regulated by miR-130b was detected using Dual Luciferase Reporter system; CSF-1 expression was negatively associated with miR-130b level in ovarian tissues and cell lines; Luciferase assay validated CSF-1 is a direct target of miR-130b; Knock-down of CSF-1 sensitized ovarian cancer cells to anticancer drugs and could partially attenuate the resistance inducing effect of miR-130b inhibitors; Downregulation of miR-130b promotes the development of multidrug resistant ovarian cancer partially by targeting the 3'-UTR of CSF-1 and the silencing of miR-130b may be mediated by DNA methylation
122 hsa-miR-148a-3p CSF1 -0.1 0.97698 -0.25 0.7772 miRNATAP -0.38 0 NA
123 hsa-miR-148b-3p CSF1 -0.2 0.91188 -0.25 0.7772 miRNAWalker2 validate -0.33 0.00151 NA
124 hsa-miR-15a-5p CSF1 -0.07 0.96484 -0.25 0.7772 miRNATAP -0.31 0.00033 NA
125 hsa-miR-15b-5p CSF1 -0.27 0.87097 -0.25 0.7772 miRNATAP -0.29 0.00029 NA
126 hsa-miR-16-5p CSF1 0.01 0.99448 -0.25 0.7772 miRNATAP -0.39 0 NA
127 hsa-miR-17-5p CSF1 -0.18 0.93454 -0.25 0.7772 TargetScan; miRNATAP -0.44 0 NA
128 hsa-miR-20a-5p CSF1 -0.18 0.92812 -0.25 0.7772 miRNATAP -0.38 0 NA
129 hsa-miR-23a-5p CSF1 -0.7 0.11889 -0.25 0.7772 MirTarget -0.13 0.00437 NA
130 hsa-miR-27a-3p CSF1 -0.12 0.9588 -0.25 0.7772 MirTarget; miRNATAP -0.37 0.00128 NA
131 hsa-miR-301a-3p CSF1 -0.11 0.83169 -0.25 0.7772 MirTarget; miRNATAP -0.28 0 NA
132 hsa-miR-30b-5p CSF1 -0.01 0.99462 -0.25 0.7772 miRNAWalker2 validate -0.46 0 NA
133 hsa-miR-30c-5p CSF1 -0.3 0.86581 -0.25 0.7772 miRNAWalker2 validate -0.47 0 NA
134 hsa-miR-335-5p CSF1 -0.03 0.97338 -0.25 0.7772 miRNAWalker2 validate -0.49 0 NA
135 hsa-miR-423-5p CSF1 -0.14 0.91245 -0.25 0.7772 miRNATAP -0.31 0.00028 NA
136 hsa-miR-424-5p CSF1 0.25 0.87015 -0.25 0.7772 miRNATAP -0.2 0.00099 NA
137 hsa-miR-429 CSF1 -0.46 0.80624 -0.25 0.7772 PITA; miRanda; miRNATAP -0.36 0 NA
138 hsa-miR-454-3p CSF1 -0.1 0.84355 -0.25 0.7772 MirTarget; miRNATAP -0.51 0 NA
139 hsa-miR-505-3p CSF1 -0.47 0.69038 -0.25 0.7772 miRNAWalker2 validate -0.37 2.0E-5 NA
140 hsa-miR-532-3p CSF1 -0.5 0.68289 -0.25 0.7772 MirTarget; PITA -0.36 0 NA
141 hsa-miR-532-5p CSF1 -0.35 0.87895 -0.25 0.7772 miRNATAP -0.29 4.0E-5 NA
142 hsa-miR-93-5p CSF1 -0.61 0.8253 -0.25 0.7772 miRNATAP -0.45 0 NA
143 hsa-miR-939-5p CSF1 -0.31 0.30445 -0.25 0.7772 MirTarget -0.27 1.0E-5 NA
144 hsa-miR-940 CSF1 -0.23 0.68006 -0.25 0.7772 MirTarget; PITA; miRNATAP -0.24 0 NA
145 hsa-miR-96-5p CSF1 0.09 0.92309 -0.25 0.7772 miRNATAP -0.43 0 NA
146 hsa-miR-1275 CSF1R -0.83 0.08038 -0.28 0.79864 MirTarget -0.28 1.0E-5 NA
147 hsa-miR-339-5p CSF1R -0.3 0.71291 -0.28 0.79864 miRanda -0.57 0 NA
148 hsa-miR-34a-5p CSF1R -0.5 0.74203 -0.28 0.79864 MirTarget; miRNATAP -0.28 0.00894 NA
149 hsa-miR-30c-2-3p EFNA1 0.24 0.74693 0.26 0.86682 MirTarget -0.32 0 NA
150 hsa-miR-9-5p EFNA1 0.45 0.79502 0.26 0.86682 miRNAWalker2 validate; miRNATAP -0.1 0.00188 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 65 498 9.453e-70 4.398e-66
2 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 65 689 2.594e-60 6.035e-57
3 INTRACELLULAR SIGNAL TRANSDUCTION 82 1572 3.995e-58 6.197e-55
4 PROTEIN PHOSPHORYLATION 68 944 1.683e-55 1.957e-52
5 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 80 1656 9.857e-54 9.173e-51
6 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 50 404 3.792e-51 2.941e-48
7 PHOSPHORYLATION 70 1228 2.074e-50 1.378e-47
8 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 81 1977 5.266e-49 3.063e-46
9 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 61 876 4.206e-48 2.174e-45
10 POSITIVE REGULATION OF RESPONSE TO STIMULUS 79 1929 1.973e-47 8.347e-45
11 POSITIVE REGULATION OF MOLECULAR FUNCTION 77 1791 1.883e-47 8.347e-45
12 POSITIVE REGULATION OF CATALYTIC ACTIVITY 72 1518 1.419e-46 5.501e-44
13 POSITIVE REGULATION OF MAPK CASCADE 47 470 1.945e-43 6.962e-41
14 REGULATION OF MAPK CASCADE 52 660 5.091e-43 1.692e-40
15 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 60 1036 1.601e-42 4.657e-40
16 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 60 1036 1.601e-42 4.657e-40
17 POSITIVE REGULATION OF CELL COMMUNICATION 68 1532 1.336e-41 3.657e-39
18 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 32 138 1.714e-41 4.431e-39
19 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 60 1135 3.131e-40 7.666e-38
20 REGULATION OF PHOSPHORUS METABOLIC PROCESS 66 1618 7.342e-38 1.708e-35
21 POSITIVE REGULATION OF KINASE ACTIVITY 42 482 4.632e-36 1.026e-33
22 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 62 1492 1.252e-35 2.648e-33
23 REGULATION OF PROTEIN MODIFICATION PROCESS 65 1710 2.552e-35 5.163e-33
24 POSITIVE REGULATION OF HYDROLASE ACTIVITY 51 905 6.886e-35 1.335e-32
25 INOSITOL LIPID MEDIATED SIGNALING 27 124 3.491e-34 6.498e-32
26 POSITIVE REGULATION OF CELL PROLIFERATION 48 814 1.447e-33 2.59e-31
27 REGULATION OF KINASE ACTIVITY 47 776 2.45e-33 4.222e-31
28 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 30 193 2.977e-33 4.947e-31
29 REGULATION OF GTPASE ACTIVITY 44 673 1.774e-32 2.847e-30
30 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 42 616 1.158e-31 1.797e-29
31 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 33 297 1.255e-31 1.884e-29
32 REGULATION OF CELL PROLIFERATION 58 1496 2.305e-31 3.352e-29
33 REGULATION OF HYDROLASE ACTIVITY 55 1327 5.412e-31 7.631e-29
34 RESPONSE TO ENDOGENOUS STIMULUS 56 1450 4.81e-30 6.583e-28
35 REGULATION OF TRANSFERASE ACTIVITY 47 946 1.721e-29 2.288e-27
36 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 61 1848 2.396e-29 3.097e-27
37 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 31 289 3.248e-29 4.085e-27
38 POSITIVE REGULATION OF LOCOMOTION 35 420 3.389e-29 4.15e-27
39 GLYCEROLIPID METABOLIC PROCESS 33 356 5.146e-29 6.14e-27
40 REGULATION OF CELLULAR COMPONENT MOVEMENT 43 771 7.485e-29 8.708e-27
41 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 58 1672 8.451e-29 9.591e-27
42 PHOSPHOLIPID METABOLIC PROCESS 33 364 1.068e-28 1.183e-26
43 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 26 172 1.653e-28 1.789e-26
44 PEPTIDYL TYROSINE MODIFICATION 26 186 1.38e-27 1.459e-25
45 REGULATION OF ERK1 AND ERK2 CASCADE 28 238 1.568e-27 1.622e-25
46 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 35 470 1.612e-27 1.63e-25
47 LOCOMOTION 48 1114 2.119e-27 2.098e-25
48 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 48 1142 6.362e-27 6.167e-25
49 LIPID PHOSPHORYLATION 21 99 1.949e-26 1.85e-24
50 POSITIVE REGULATION OF MAP KINASE ACTIVITY 26 207 2.434e-26 2.265e-24
51 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 45 1021 5.782e-26 5.275e-24
52 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 51 1395 6.041e-26 5.405e-24
53 REGULATION OF MAP KINASE ACTIVITY 29 319 3.049e-25 2.677e-23
54 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 44 1008 3.535e-25 3.046e-23
55 REGULATION OF VASCULATURE DEVELOPMENT 26 233 5.601e-25 4.739e-23
56 RESPONSE TO GROWTH FACTOR 32 475 8.794e-24 7.307e-22
57 RESPONSE TO OXYGEN CONTAINING COMPOUND 48 1381 2.525e-23 2.062e-21
58 BLOOD VESSEL MORPHOGENESIS 28 364 2.22e-22 1.781e-20
59 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 16 62 7.318e-22 5.771e-20
60 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 15 49 7.877e-22 6.109e-20
61 RESPONSE TO NITROGEN COMPOUND 38 859 8.642e-22 6.592e-20
62 VASCULATURE DEVELOPMENT 30 469 1.201e-21 9.015e-20
63 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 27 352 1.47e-21 1.086e-19
64 REGULATION OF CELL DEATH 47 1472 2.94e-21 2.137e-19
65 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 44 1275 4.132e-21 2.958e-19
66 TAXIS 29 464 1.188e-20 8.376e-19
67 POSITIVE REGULATION OF CELL DIVISION 19 132 1.371e-20 9.522e-19
68 GLYCEROLIPID BIOSYNTHETIC PROCESS 22 211 1.44e-20 9.852e-19
69 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 19 133 1.591e-20 1.073e-18
70 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 24 278 2.012e-20 1.338e-18
71 REGULATION OF ENDOTHELIAL CELL MIGRATION 18 114 2.616e-20 1.715e-18
72 CARDIOVASCULAR SYSTEM DEVELOPMENT 35 788 4.388e-20 2.797e-18
73 CIRCULATORY SYSTEM DEVELOPMENT 35 788 4.388e-20 2.797e-18
74 RAS PROTEIN SIGNAL TRANSDUCTION 19 143 6.607e-20 4.154e-18
75 RESPONSE TO EXTERNAL STIMULUS 50 1821 6.804e-20 4.221e-18
76 ANGIOGENESIS 24 293 6.942e-20 4.25e-18
77 PHOSPHOLIPID BIOSYNTHETIC PROCESS 22 235 1.533e-19 9.264e-18
78 REGULATION OF CELL DIFFERENTIATION 45 1492 2.612e-19 1.558e-17
79 LIPID MODIFICATION 21 210 2.758e-19 1.6e-17
80 CELL MOTILITY 35 835 2.785e-19 1.6e-17
81 LOCALIZATION OF CELL 35 835 2.785e-19 1.6e-17
82 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 21 213 3.713e-19 2.107e-17
83 REGULATION OF EPITHELIAL CELL MIGRATION 19 166 1.192e-18 6.683e-17
84 ORGANOPHOSPHATE METABOLIC PROCESS 35 885 1.751e-18 9.702e-17
85 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 33 799 5.614e-18 3.073e-16
86 ACTIVATION OF PROTEIN KINASE ACTIVITY 22 279 6.276e-18 3.396e-16
87 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 18 154 6.969e-18 3.727e-16
88 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 19 184 8.546e-18 4.519e-16
89 NEGATIVE REGULATION OF CELL DEATH 34 872 9.243e-18 4.832e-16
90 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 40 1.473e-17 7.617e-16
91 REGULATION OF IMMUNE SYSTEM PROCESS 41 1403 5.218e-17 2.668e-15
92 REGULATION OF CELL DIVISION 21 272 5.816e-17 2.941e-15
93 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 16 120 6.095e-17 3.049e-15
94 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 13 61 9.101e-17 4.505e-15
95 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 22 323 1.41e-16 6.905e-15
96 CELLULAR RESPONSE TO NITROGEN COMPOUND 26 505 1.702e-16 8.251e-15
97 REGULATION OF LIPID KINASE ACTIVITY 12 48 1.759e-16 8.439e-15
98 REGULATION OF PHOSPHOLIPASE ACTIVITY 13 64 1.791e-16 8.506e-15
99 REGULATION OF LIPASE ACTIVITY 14 83 1.901e-16 8.936e-15
100 CELLULAR LIPID METABOLIC PROCESS 33 913 2.866e-16 1.333e-14
101 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 13 67 3.404e-16 1.568e-14
102 PROTEIN AUTOPHOSPHORYLATION 18 192 3.728e-16 1.7e-14
103 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 17 162 3.844e-16 1.737e-14
104 CELL DEVELOPMENT 40 1426 5.71e-16 2.555e-14
105 REGULATION OF PHOSPHOLIPASE C ACTIVITY 11 39 7.486e-16 3.317e-14
106 POSITIVE REGULATION OF CELL DIFFERENTIATION 31 823 8.84e-16 3.88e-14
107 RESPONSE TO HORMONE 32 893 1.134e-15 4.932e-14
108 FC RECEPTOR SIGNALING PATHWAY 18 206 1.301e-15 5.606e-14
109 REGULATION OF EPITHELIAL CELL PROLIFERATION 20 285 2.152e-15 9.186e-14
110 REGULATION OF CHEMOTAXIS 17 180 2.291e-15 9.691e-14
111 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 32 926 3.144e-15 1.318e-13
112 REGULATION OF CELL ADHESION 27 629 3.693e-15 1.534e-13
113 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 103 4.441e-15 1.829e-13
114 TISSUE DEVELOPMENT 40 1518 4.688e-15 1.914e-13
115 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 34 1.005e-14 4.068e-13
116 REGULATION OF TRANSPORT 43 1804 1.093e-14 4.383e-13
117 POSITIVE REGULATION OF LIPASE ACTIVITY 12 66 1.128e-14 4.484e-13
118 PEPTIDYL AMINO ACID MODIFICATION 30 841 1.186e-14 4.678e-13
119 POSITIVE CHEMOTAXIS 10 36 1.928e-14 7.538e-13
120 POSITIVE REGULATION OF TRANSPORT 31 936 2.925e-14 1.134e-12
121 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 11 53 3.155e-14 1.213e-12
122 POSITIVE REGULATION OF CHEMOTAXIS 14 120 3.942e-14 1.503e-12
123 REGULATION OF NEURON DEATH 18 252 4.425e-14 1.674e-12
124 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 74 4.813e-14 1.806e-12
125 REGULATION OF RESPONSE TO STRESS 38 1468 4.905e-14 1.826e-12
126 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 22 450 1.322e-13 4.883e-12
127 RESPONSE TO WOUNDING 24 563 1.781e-13 6.526e-12
128 CELLULAR RESPONSE TO PEPTIDE 18 274 1.869e-13 6.793e-12
129 LIPID METABOLIC PROCESS 33 1158 2.499e-13 9.015e-12
130 REGULATION OF LIPID METABOLIC PROCESS 18 282 3.057e-13 1.094e-11
131 WOUND HEALING 22 470 3.171e-13 1.126e-11
132 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 9 32 3.603e-13 1.27e-11
133 FC EPSILON RECEPTOR SIGNALING PATHWAY 14 142 4.192e-13 1.467e-11
134 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 18 296 6.97e-13 2.42e-11
135 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 8 22 7.128e-13 2.457e-11
136 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 51 8.934e-13 3.057e-11
137 LEUKOCYTE MIGRATION 17 259 9.308e-13 3.161e-11
138 CELLULAR RESPONSE TO HORMONE STIMULUS 23 552 9.689e-13 3.267e-11
139 PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 8 23 1.087e-12 3.639e-11
140 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 28 867 1.189e-12 3.952e-11
141 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 7 14 1.302e-12 4.298e-11
142 IMMUNE SYSTEM PROCESS 42 1984 1.372e-12 4.494e-11
143 RESPONSE TO PEPTIDE 20 404 1.514e-12 4.925e-11
144 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 12 98 1.564e-12 5.054e-11
145 REGULATION OF NEURON APOPTOTIC PROCESS 15 192 1.796e-12 5.764e-11
146 NEUROGENESIS 35 1402 1.832e-12 5.84e-11
147 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 13 128 2.042e-12 6.463e-11
148 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 29 957 2.111e-12 6.637e-11
149 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 9 39 2.621e-12 8.185e-11
150 IMMUNE SYSTEM DEVELOPMENT 23 582 2.868e-12 8.898e-11
151 CELL CELL SIGNALING 26 767 2.935e-12 9.044e-11
152 REGULATION OF CELL DEVELOPMENT 27 836 3.22e-12 9.857e-11
153 PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 8 26 3.408e-12 1.037e-10
154 ORGAN MORPHOGENESIS 27 841 3.697e-12 1.117e-10
155 LIPID BIOSYNTHETIC PROCESS 22 539 4.803e-12 1.442e-10
156 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 9 42 5.426e-12 1.608e-10
157 NEGATIVE REGULATION OF NEURON DEATH 14 171 5.426e-12 1.608e-10
158 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 84 6.498e-12 1.914e-10
159 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 31 1152 6.848e-12 2.004e-10
160 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 17 7.262e-12 2.112e-10
161 TUBE DEVELOPMENT 22 552 7.658e-12 2.213e-10
162 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 25 750 1.179e-11 3.386e-10
163 CELL PROJECTION ORGANIZATION 27 902 1.845e-11 5.259e-10
164 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 68 1.854e-11 5.259e-10
165 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 38 1805 2.745e-11 7.74e-10
166 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 2.881e-11 8.077e-10
167 REGULATION OF IMMUNE RESPONSE 26 858 3.551e-11 9.895e-10
168 CELL PROLIFERATION 23 672 5.199e-11 1.44e-09
169 EPITHELIUM DEVELOPMENT 27 945 5.299e-11 1.459e-09
170 RESPONSE TO ABIOTIC STIMULUS 28 1024 6.051e-11 1.656e-09
171 REGULATION OF AXONOGENESIS 13 168 6.578e-11 1.79e-09
172 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 55 7.211e-11 1.951e-09
173 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 12 135 7.285e-11 1.959e-09
174 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 8 37 7.938e-11 2.123e-09
175 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 32 1360 9.547e-11 2.539e-09
176 INSULIN RECEPTOR SIGNALING PATHWAY 10 80 9.836e-11 2.6e-09
177 REGULATION OF NEURON PROJECTION DEVELOPMENT 18 408 1.433e-10 3.768e-09
178 HEAD DEVELOPMENT 23 709 1.5e-10 3.92e-09
179 REGULATION OF GLUCOSE IMPORT 9 60 1.632e-10 4.242e-09
180 POSITIVE REGULATION OF CELL DEVELOPMENT 19 472 1.999e-10 5.168e-09
181 POSITIVE REGULATION OF DNA REPLICATION 10 86 2.047e-10 5.235e-09
182 REGULATED EXOCYTOSIS 14 224 2.037e-10 5.235e-09
183 RESPONSE TO FIBROBLAST GROWTH FACTOR 11 116 2.311e-10 5.877e-09
184 POSITIVE REGULATION OF GLUCOSE TRANSPORT 8 42 2.362e-10 5.973e-09
185 PHOSPHATIDYLCHOLINE METABOLIC PROCESS 9 64 2.975e-10 7.482e-09
186 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 27 3.143e-10 7.864e-09
187 NEURON PROJECTION DEVELOPMENT 20 545 3.241e-10 8.064e-09
188 POSITIVE REGULATION OF CELL ADHESION 17 376 3.33e-10 8.243e-09
189 REGULATION OF CELL MORPHOGENESIS 20 552 4.049e-10 9.968e-09
190 SPROUTING ANGIOGENESIS 8 45 4.245e-10 1.04e-08
191 REGULATION OF NEURON DIFFERENTIATION 20 554 4.312e-10 1.05e-08
192 REGULATION OF CELLULAR LOCALIZATION 30 1277 4.387e-10 1.063e-08
193 EMBRYO DEVELOPMENT 25 894 4.818e-10 1.16e-08
194 REGULATION OF CELL PROJECTION ORGANIZATION 20 558 4.887e-10 1.16e-08
195 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 16 4.864e-10 1.16e-08
196 PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 6 16 4.864e-10 1.16e-08
197 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 337 5.644e-10 1.333e-08
198 CELL ACTIVATION 20 568 6.652e-10 1.563e-08
199 GLAND DEVELOPMENT 17 395 7.079e-10 1.65e-08
200 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 7 30 7.092e-10 1.65e-08
201 PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 6 17 7.478e-10 1.731e-08
202 RESPONSE TO ORGANIC CYCLIC COMPOUND 25 917 8.137e-10 1.874e-08
203 MORPHOGENESIS OF AN EPITHELIUM 17 400 8.573e-10 1.965e-08
204 PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 7 31 9.111e-10 2.068e-08
205 RHYTHMIC PROCESS 15 298 9.078e-10 2.068e-08
206 REGULATION OF GLUCOSE TRANSPORT 10 100 9.277e-10 2.096e-08
207 GROWTH 17 410 1.247e-09 2.803e-08
208 REGULATION OF CELL SUBSTRATE ADHESION 12 173 1.302e-09 2.912e-08
209 REGULATION OF ORGANELLE ORGANIZATION 28 1178 1.46e-09 3.251e-08
210 CENTRAL NERVOUS SYSTEM DEVELOPMENT 24 872 1.551e-09 3.436e-08
211 PLATELET DEGRANULATION 10 107 1.813e-09 3.998e-08
212 ERBB SIGNALING PATHWAY 9 79 2.05e-09 4.499e-08
213 RESPONSE TO LIPID 24 888 2.22e-09 4.849e-08
214 CELLULAR RESPONSE TO INSULIN STIMULUS 11 146 2.734e-09 5.944e-08
215 POSITIVE REGULATION OF DNA METABOLIC PROCESS 12 185 2.799e-09 6.058e-08
216 NEURON DEVELOPMENT 21 687 2.998e-09 6.458e-08
217 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 9 85 3.97e-09 8.473e-08
218 EPHRIN RECEPTOR SIGNALING PATHWAY 9 85 3.97e-09 8.473e-08
219 CELLULAR RESPONSE TO GLUCAGON STIMULUS 7 38 4.212e-09 8.949e-08
220 REGULATION OF HOMEOSTATIC PROCESS 17 447 4.567e-09 9.66e-08
221 ERBB2 SIGNALING PATHWAY 7 39 5.106e-09 1.075e-07
222 REGULATION OF DEVELOPMENTAL GROWTH 14 289 5.577e-09 1.169e-07
223 REGULATION OF ORGAN MORPHOGENESIS 13 242 5.873e-09 1.225e-07
224 REGULATION OF PROTEIN KINASE B SIGNALING 10 121 6.051e-09 1.257e-07
225 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 7 40 6.156e-09 1.273e-07
226 LEUKOCYTE DIFFERENTIATION 14 292 6.362e-09 1.31e-07
227 MIDBRAIN DEVELOPMENT 9 90 6.628e-09 1.353e-07
228 REGULATION OF CELL MATRIX ADHESION 9 90 6.628e-09 1.353e-07
229 SECRETION 19 588 7.539e-09 1.532e-07
230 REGULATION OF POSITIVE CHEMOTAXIS 6 24 7.837e-09 1.586e-07
231 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 162 8.179e-09 1.648e-07
232 NEURON DIFFERENTIATION 23 874 8.31e-09 1.667e-07
233 HEART DEVELOPMENT 17 466 8.475e-09 1.693e-07
234 RESPONSE TO INSULIN 12 205 8.924e-09 1.775e-07
235 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 25 1.026e-08 2.014e-07
236 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 6 25 1.026e-08 2.014e-07
237 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 14 303 1.018e-08 2.014e-07
238 RESPONSE TO RADIATION 16 413 1.038e-08 2.029e-07
239 EXOCYTOSIS 14 310 1.358e-08 2.645e-07
240 CELLULAR COMPONENT MORPHOGENESIS 23 900 1.434e-08 2.781e-07
241 POSITIVE REGULATION OF AXONOGENESIS 8 69 1.447e-08 2.793e-07
242 SECRETION BY CELL 17 486 1.574e-08 3.027e-07
243 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 24 983 1.595e-08 3.054e-07
244 ACTIVATION OF MAPK ACTIVITY 10 137 2.011e-08 3.834e-07
245 PHOSPHATIDYLSERINE METABOLIC PROCESS 6 28 2.148e-08 4.079e-07
246 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 16 437 2.288e-08 4.328e-07
247 RESPONSE TO GLUCAGON 7 48 2.329e-08 4.388e-07
248 REGULATION OF CELL CELL ADHESION 15 380 2.416e-08 4.533e-07
249 REGULATION OF BODY FLUID LEVELS 17 506 2.838e-08 5.303e-07
250 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 12 229 3.063e-08 5.701e-07
251 POSITIVE REGULATION OF CELL CYCLE 14 332 3.213e-08 5.955e-07
252 RESPONSE TO LIGHT STIMULUS 13 280 3.33e-08 6.148e-07
253 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 12 232 3.537e-08 6.504e-07
254 REGULATION OF PROTEIN LOCALIZATION 23 950 3.879e-08 7.107e-07
255 POSITIVE REGULATION OF GROWTH 12 238 4.685e-08 8.549e-07
256 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 7 53 4.748e-08 8.597e-07
257 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 7 53 4.748e-08 8.597e-07
258 NEURON PROJECTION MORPHOGENESIS 15 402 5.067e-08 9.104e-07
259 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 6 32 5.059e-08 9.104e-07
260 REGULATION OF FIBROBLAST PROLIFERATION 8 81 5.217e-08 9.301e-07
261 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 8 81 5.217e-08 9.301e-07
262 ALCOHOL METABOLIC PROCESS 14 348 5.768e-08 1.024e-06
263 PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 5 17 6.005e-08 1.057e-06
264 TISSUE MORPHOGENESIS 17 533 6.021e-08 1.057e-06
265 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 17 6.005e-08 1.057e-06
266 REPRODUCTIVE SYSTEM DEVELOPMENT 15 408 6.15e-08 1.076e-06
267 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 197 6.193e-08 1.079e-06
268 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 18 602 6.305e-08 1.095e-06
269 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 10 156 6.93e-08 1.199e-06
270 COGNITION 12 251 8.388e-08 1.445e-06
271 ALDITOL PHOSPHATE METABOLIC PROCESS 6 35 8.918e-08 1.531e-06
272 HOMEOSTATIC PROCESS 27 1337 9.148e-08 1.565e-06
273 REGULATION OF CELL ACTIVATION 16 484 9.355e-08 1.588e-06
274 REGULATION OF DNA REPLICATION 10 161 9.334e-08 1.588e-06
275 RESPONSE TO ALCOHOL 14 362 9.383e-08 1.588e-06
276 REGULATION OF STEM CELL PROLIFERATION 8 88 1.004e-07 1.687e-06
277 REGULATION OF INTRACELLULAR TRANSPORT 18 621 1.004e-07 1.687e-06
278 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 7 59 1.018e-07 1.703e-06
279 REGULATION OF CELLULAR COMPONENT BIOGENESIS 20 767 1.024e-07 1.707e-06
280 KIDNEY VASCULATURE DEVELOPMENT 5 19 1.117e-07 1.849e-06
281 RENAL SYSTEM VASCULATURE DEVELOPMENT 5 19 1.117e-07 1.849e-06
282 HEMOSTASIS 13 311 1.134e-07 1.871e-06
283 REGULATION OF ACTIN FILAMENT BASED PROCESS 13 312 1.177e-07 1.935e-06
284 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 1.288e-07 2.11e-06
285 MORPHOGENESIS OF A BRANCHING STRUCTURE 10 167 1.316e-07 2.149e-06
286 REGULATION OF GROWTH 18 633 1.335e-07 2.172e-06
287 AMMONIUM ION METABOLIC PROCESS 10 169 1.472e-07 2.386e-06
288 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 6 39 1.755e-07 2.826e-06
289 TUBE MORPHOGENESIS 13 323 1.755e-07 2.826e-06
290 AMINE METABOLIC PROCESS 9 131 1.777e-07 2.851e-06
291 CHEMICAL HOMEOSTASIS 21 874 1.862e-07 2.977e-06
292 REPRODUCTION 26 1297 1.917e-07 3.054e-06
293 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 513 2.059e-07 3.269e-06
294 SYSTEM PROCESS 31 1785 2.509e-07 3.971e-06
295 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 5 23 3.166e-07 4.959e-06
296 REGULATION OF DNA METABOLIC PROCESS 13 340 3.155e-07 4.959e-06
297 NEUROTROPHIN SIGNALING PATHWAY 5 23 3.166e-07 4.959e-06
298 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 11 232 3.232e-07 5.047e-06
299 PLATELET ACTIVATION 9 142 3.537e-07 5.505e-06
300 EMBRYONIC ORGAN DEVELOPMENT 14 406 3.787e-07 5.873e-06
301 REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 5 24 3.978e-07 6.149e-06
302 SUBSTANTIA NIGRA DEVELOPMENT 6 45 4.245e-07 6.519e-06
303 EXOCRINE SYSTEM DEVELOPMENT 6 45 4.245e-07 6.519e-06
304 POSITIVE REGULATION OF GENE EXPRESSION 30 1733 4.417e-07 6.761e-06
305 REGULATION OF CELLULAR RESPONSE TO STRESS 18 691 4.833e-07 7.373e-06
306 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 15 482 5.227e-07 7.948e-06
307 UROGENITAL SYSTEM DEVELOPMENT 12 299 5.511e-07 8.353e-06
308 NEGATIVE REGULATION OF CELL COMMUNICATION 24 1192 5.696e-07 8.604e-06
309 MODULATION OF SYNAPTIC TRANSMISSION 12 301 5.914e-07 8.906e-06
310 RESPIRATORY SYSTEM DEVELOPMENT 10 197 6.091e-07 9.142e-06
311 CELL PART MORPHOGENESIS 17 633 6.806e-07 1.018e-05
312 ACTIVATION OF IMMUNE RESPONSE 14 427 6.923e-07 1.032e-05
313 OVULATION CYCLE 8 113 6.987e-07 1.039e-05
314 POSITIVE REGULATION OF NEURON DIFFERENTIATION 12 306 7.04e-07 1.04e-05
315 AMEBOIDAL TYPE CELL MIGRATION 9 154 7.023e-07 1.04e-05
316 POSITIVE REGULATION OF IMMUNE RESPONSE 16 563 7.106e-07 1.046e-05
317 REGULATION OF HOMOTYPIC CELL CELL ADHESION 12 307 7.287e-07 1.07e-05
318 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 7.439e-07 1.089e-05
319 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 13 368 7.719e-07 1.126e-05
320 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 4 12 7.856e-07 1.142e-05
321 NEPHRON DEVELOPMENT 8 115 7.99e-07 1.158e-05
322 VISUAL BEHAVIOR 6 50 8.067e-07 1.166e-05
323 RESPONSE TO OXYGEN LEVELS 12 311 8.352e-07 1.203e-05
324 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 7 80 8.472e-07 1.217e-05
325 REGULATION OF CYTOSKELETON ORGANIZATION 15 502 8.707e-07 1.247e-05
326 NEURON PROJECTION GUIDANCE 10 205 8.764e-07 1.251e-05
327 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 19 801 9.264e-07 1.318e-05
328 REGULATION OF CALCIUM ION TRANSPORT 10 209 1.045e-06 1.482e-05
329 INDUCTION OF POSITIVE CHEMOTAXIS 4 13 1.129e-06 1.597e-05
330 VESICLE MEDIATED TRANSPORT 24 1239 1.134e-06 1.598e-05
331 TISSUE MIGRATION 7 84 1.182e-06 1.662e-05
332 SINGLE ORGANISM BEHAVIOR 13 384 1.242e-06 1.74e-05
333 ACTIN FILAMENT BASED PROCESS 14 450 1.288e-06 1.8e-05
334 POSITIVE REGULATION OF MITOTIC CELL CYCLE 8 123 1.333e-06 1.856e-05
335 SKELETAL SYSTEM DEVELOPMENT 14 455 1.466e-06 2.037e-05
336 REGULATION OF PLATELET ACTIVATION 5 31 1.534e-06 2.124e-05
337 OVULATION CYCLE PROCESS 7 88 1.622e-06 2.233e-05
338 REGULATION OF CATION CHANNEL ACTIVITY 7 88 1.622e-06 2.233e-05
339 DEVELOPMENTAL GROWTH 12 333 1.707e-06 2.343e-05
340 REGULATION OF VESICLE MEDIATED TRANSPORT 14 462 1.754e-06 2.4e-05
341 SALIVARY GLAND DEVELOPMENT 5 32 1.808e-06 2.468e-05
342 POSITIVE REGULATION OF CELL DEATH 16 605 1.817e-06 2.472e-05
343 NEGATIVE REGULATION OF CELL ADHESION 10 223 1.878e-06 2.548e-05
344 HOMEOSTASIS OF NUMBER OF CELLS 9 175 2.039e-06 2.758e-05
345 PHOSPHATIDIC ACID METABOLIC PROCESS 5 33 2.12e-06 2.86e-05
346 LEARNING 8 131 2.144e-06 2.875e-05
347 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 8 131 2.144e-06 2.875e-05
348 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 59 2.181e-06 2.917e-05
349 B CELL ACTIVATION 8 132 2.27e-06 3.027e-05
350 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 60 2.411e-06 3.205e-05
351 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 2.473e-06 3.278e-05
352 REGULATION OF SECRETION 17 699 2.626e-06 3.471e-05
353 FC GAMMA RECEPTOR SIGNALING PATHWAY 7 95 2.72e-06 3.586e-05
354 REGULATION OF RESPONSE TO WOUNDING 13 413 2.773e-06 3.645e-05
355 REGULATION OF CYTOPLASMIC TRANSPORT 14 481 2.803e-06 3.674e-05
356 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 5 35 2.87e-06 3.741e-05
357 REGULATION OF CELL CYCLE 20 949 2.866e-06 3.741e-05
358 MYELOID LEUKOCYTE DIFFERENTIATION 7 96 2.919e-06 3.793e-05
359 GLAND MORPHOGENESIS 7 97 3.129e-06 4.044e-05
360 POSITIVE REGULATION OF ION TRANSPORT 10 236 3.12e-06 4.044e-05
361 MEMORY 7 98 3.352e-06 4.32e-05
362 FOREBRAIN DEVELOPMENT 12 357 3.502e-06 4.501e-05
363 REGULATION OF SYNAPTIC PLASTICITY 8 140 3.526e-06 4.52e-05
364 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 7 99 3.587e-06 4.586e-05
365 MYELOID CELL DIFFERENTIATION 9 189 3.84e-06 4.895e-05
366 STEM CELL DIFFERENTIATION 9 190 4.009e-06 5.096e-05
367 RESPONSE TO STEROID HORMONE 14 497 4.088e-06 5.183e-05
368 NEURAL NUCLEUS DEVELOPMENT 6 66 4.24e-06 5.361e-05
369 SINGLE ORGANISM BIOSYNTHETIC PROCESS 24 1340 4.425e-06 5.565e-05
370 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 15 573 4.424e-06 5.565e-05
371 LIPID CATABOLIC PROCESS 10 247 4.677e-06 5.849e-05
372 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 103 4.674e-06 5.849e-05
373 MAST CELL MEDIATED IMMUNITY 4 18 4.713e-06 5.879e-05
374 RESPONSE TO ESTRADIOL 8 146 4.817e-06 5.993e-05
375 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 9 195 4.954e-06 6.147e-05
376 ASTROCYTE DIFFERENTIATION 5 39 4.987e-06 6.155e-05
377 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 4.985e-06 6.155e-05
378 REGULATION OF CELL JUNCTION ASSEMBLY 6 68 5.054e-06 6.205e-05
379 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 12 370 5.045e-06 6.205e-05
380 CEREBRAL CORTEX DEVELOPMENT 7 105 5.312e-06 6.505e-05
381 OSSIFICATION 10 251 5.39e-06 6.582e-05
382 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 7 106 5.658e-06 6.888e-05
383 POSITIVE REGULATION OF CELL MATRIX ADHESION 5 40 5.67e-06 6.888e-05
384 EPIDERMIS DEVELOPMENT 10 253 5.78e-06 7.004e-05
385 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 5.939e-06 7.16e-05
386 MACROPHAGE DIFFERENTIATION 4 19 5.939e-06 7.16e-05
387 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 70 5.991e-06 7.203e-05
388 REGULATION OF ION HOMEOSTASIS 9 201 6.336e-06 7.599e-05
389 CELL DEATH 20 1001 6.366e-06 7.614e-05
390 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 6.424e-06 7.645e-05
391 MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 41 6.424e-06 7.645e-05
392 SKIN EPIDERMIS DEVELOPMENT 6 71 6.509e-06 7.727e-05
393 RESPONSE TO ACID CHEMICAL 11 319 7.153e-06 8.469e-05
394 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 5 42 7.255e-06 8.567e-05
395 EMBRYONIC HEMOPOIESIS 4 20 7.387e-06 8.68e-05
396 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 4 20 7.387e-06 8.68e-05
397 ASSOCIATIVE LEARNING 6 73 7.656e-06 8.973e-05
398 BONE DEVELOPMENT 8 156 7.855e-06 9.183e-05
399 REGULATION OF PROTEIN SECRETION 12 389 8.372e-06 9.764e-05
400 REGULATION OF METAL ION TRANSPORT 11 325 8.526e-06 9.918e-05
401 SEX DIFFERENTIATION 10 266 8.971e-06 0.0001041
402 REGULATION OF JNK CASCADE 8 159 9.033e-06 0.0001046
403 MAST CELL ACTIVATION 4 21 9.08e-06 0.0001048
404 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 7 116 1.026e-05 0.0001179
405 FEMALE SEX DIFFERENTIATION 7 116 1.026e-05 0.0001179
406 CELL CHEMOTAXIS 8 162 1.036e-05 0.0001187
407 SOMATIC STEM CELL DIVISION 4 22 1.104e-05 0.0001262
408 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 9 216 1.131e-05 0.000129
409 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 118 1.148e-05 0.0001306
410 RESPONSE TO ESTROGEN 9 218 1.218e-05 0.0001382
411 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 47 1.275e-05 0.0001443
412 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 12 406 1.285e-05 0.0001451
413 LYSOSOME LOCALIZATION 4 23 1.33e-05 0.0001498
414 REGULATION OF CELLULAR PROTEIN LOCALIZATION 14 552 1.343e-05 0.0001509
415 RESPONSE TO INORGANIC SUBSTANCE 13 479 1.367e-05 0.0001532
416 RESPONSE TO AMINE 5 48 1.416e-05 0.0001584
417 RESPONSE TO CYTOKINE 16 714 1.47e-05 0.000164
418 MUSCLE SYSTEM PROCESS 10 282 1.49e-05 0.0001658
419 JNK CASCADE 6 82 1.502e-05 0.0001668
420 LEUKOCYTE ACTIVATION 12 414 1.559e-05 0.0001725
421 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 5 49 1.569e-05 0.0001725
422 GLOMERULUS DEVELOPMENT 5 49 1.569e-05 0.0001725
423 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 5 49 1.569e-05 0.0001725
424 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 4 24 1.588e-05 0.0001743
425 ORGAN REGENERATION 6 83 1.611e-05 0.0001755
426 HAIR CYCLE 6 83 1.611e-05 0.0001755
427 MOLTING CYCLE 6 83 1.611e-05 0.0001755
428 REGULATION OF WOUND HEALING 7 126 1.762e-05 0.0001916
429 CELLULAR RESPONSE TO ACID CHEMICAL 8 175 1.815e-05 0.0001968
430 SENSORY ORGAN DEVELOPMENT 13 493 1.851e-05 0.0002002
431 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 4 25 1.881e-05 0.0002031
432 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 5 51 1.912e-05 0.000206
433 CELLULAR CHEMICAL HOMEOSTASIS 14 570 1.918e-05 0.0002061
434 REGULATION OF LIPID BIOSYNTHETIC PROCESS 7 128 1.952e-05 0.0002093
435 REGULATION OF LEUKOCYTE DIFFERENTIATION 9 232 1.997e-05 0.0002136
436 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 6 88 2.252e-05 0.0002404
437 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 7 131 2.268e-05 0.0002415
438 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 5 53 2.312e-05 0.0002451
439 CELLULAR RESPONSE TO AMINO ACID STIMULUS 5 53 2.312e-05 0.0002451
440 MUSCLE STRUCTURE DEVELOPMENT 12 432 2.373e-05 0.0002509
441 POSITIVE REGULATION OF CALCIUM ION IMPORT 5 54 2.535e-05 0.0002669
442 B CELL RECEPTOR SIGNALING PATHWAY 5 54 2.535e-05 0.0002669
443 REGULATION OF OXIDOREDUCTASE ACTIVITY 6 90 2.561e-05 0.0002684
444 CALCIUM MEDIATED SIGNALING 6 90 2.561e-05 0.0002684
445 CIRCULATORY SYSTEM PROCESS 11 366 2.571e-05 0.0002688
446 POSITIVE REGULATION OF HEART GROWTH 4 27 2.584e-05 0.000269
447 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 27 2.584e-05 0.000269
448 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 12 437 2.656e-05 0.0002758
449 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 135 2.754e-05 0.0002847
450 CELL GROWTH 7 135 2.754e-05 0.0002847
451 REGULATION OF KIDNEY DEVELOPMENT 5 55 2.774e-05 0.0002862
452 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 13 514 2.858e-05 0.0002942
453 POSITIVE REGULATION OF CELL CELL ADHESION 9 243 2.876e-05 0.0002954
454 BEHAVIOR 13 516 2.975e-05 0.0003049
455 REGULATION OF SPROUTING ANGIOGENESIS 4 28 3e-05 0.0003067
456 MESENCHYME DEVELOPMENT 8 190 3.275e-05 0.0003342
457 ENDOTHELIAL CELL MIGRATION 5 57 3.305e-05 0.0003365
458 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 7 139 3.323e-05 0.0003375
459 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 3.462e-05 0.0003494
460 STEM CELL DIVISION 4 29 3.462e-05 0.0003494
461 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 3.462e-05 0.0003494
462 REGULATION OF HEMOPOIESIS 10 314 3.731e-05 0.0003758
463 CONNECTIVE TISSUE DEVELOPMENT 8 194 3.799e-05 0.0003818
464 INFLAMMATORY RESPONSE 12 454 3.85e-05 0.0003861
465 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 5 59 3.911e-05 0.0003905
466 VASCULOGENESIS 5 59 3.911e-05 0.0003905
467 LEUKOCYTE DEGRANULATION 4 30 3.975e-05 0.0003927
468 RESPONSE TO AMPHETAMINE 4 30 3.975e-05 0.0003927
469 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 4 30 3.975e-05 0.0003927
470 NEGATIVE REGULATION OF CELL DIFFERENTIATION 14 609 3.96e-05 0.0003927
471 REGULATION OF VASCULAR PERMEABILITY 4 30 3.975e-05 0.0003927
472 MYELOID LEUKOCYTE ACTIVATION 6 98 4.151e-05 0.0004092
473 CHEMICAL HOMEOSTASIS WITHIN A TISSUE 3 11 4.165e-05 0.0004097
474 REGULATION OF TRANSPORTER ACTIVITY 8 198 4.391e-05 0.000431
475 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 10 321 4.493e-05 0.0004401
476 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 4 31 4.541e-05 0.000442
477 T CELL RECEPTOR SIGNALING PATHWAY 7 146 4.549e-05 0.000442
478 REGULATION OF ENDOCYTOSIS 8 199 4.55e-05 0.000442
479 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 4 31 4.541e-05 0.000442
480 OVARIAN FOLLICLE DEVELOPMENT 5 61 4.6e-05 0.000445
481 POSITIVE REGULATION OF CYCLASE ACTIVITY 5 61 4.6e-05 0.000445
482 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 4.652e-05 0.0004491
483 DIGESTIVE SYSTEM DEVELOPMENT 7 148 4.96e-05 0.0004779
484 POSITIVE REGULATION OF NUCLEAR DIVISION 5 62 4.978e-05 0.0004786
485 REGULATION OF MITOTIC CELL CYCLE 12 468 5.159e-05 0.000495
486 REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 3 12 5.527e-05 0.0005281
487 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 3 12 5.527e-05 0.0005281
488 REGULATION OF LEUKOCYTE PROLIFERATION 8 206 5.807e-05 0.0005526
489 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 5 64 5.805e-05 0.0005526
490 PALLIUM DEVELOPMENT 7 153 6.124e-05 0.0005816
491 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 13 554 6.159e-05 0.0005837
492 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 8 208 6.216e-05 0.0005878
493 LYMPHOCYTE DIFFERENTIATION 8 209 6.428e-05 0.0006067
494 NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 4 34 6.594e-05 0.000621
495 RESPONSE TO MECHANICAL STIMULUS 8 210 6.647e-05 0.0006248
496 REGULATION OF MULTICELLULAR ORGANISM GROWTH 5 66 6.735e-05 0.0006318
497 REGULATION OF SEQUESTERING OF CALCIUM ION 6 107 6.798e-05 0.0006365
498 MULTICELLULAR ORGANISMAL HOMEOSTASIS 9 272 6.896e-05 0.0006443
499 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 7 156 6.924e-05 0.0006456
500 NEURONAL STEM CELL DIVISION 3 13 7.152e-05 0.0006624
501 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 7.152e-05 0.0006624
502 NEUROBLAST DIVISION 3 13 7.152e-05 0.0006624
503 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 6 108 7.16e-05 0.0006624
504 POSITIVE REGULATION OF NEURON DEATH 5 67 7.241e-05 0.0006685
505 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 9 274 7.294e-05 0.000672
506 MULTI MULTICELLULAR ORGANISM PROCESS 8 213 7.341e-05 0.0006751
507 IMMUNE EFFECTOR PROCESS 12 486 7.397e-05 0.0006789
508 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 6 109 7.538e-05 0.0006904
509 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 5 68 7.775e-05 0.0007108
510 SECOND MESSENGER MEDIATED SIGNALING 7 160 8.12e-05 0.0007409
511 REGENERATION 7 161 8.445e-05 0.0007689
512 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 218 8.632e-05 0.0007844
513 RESPONSE TO AMINO ACID 6 112 8.766e-05 0.0007951
514 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 3 14 9.059e-05 0.0008153
515 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 14 9.059e-05 0.0008153
516 REGULATION OF GLOMERULUS DEVELOPMENT 3 14 9.059e-05 0.0008153
517 REGULATION OF PROTEIN KINASE C SIGNALING 3 14 9.059e-05 0.0008153
518 POSITIVE REGULATION OF HEMOPOIESIS 7 163 9.125e-05 0.0008196
519 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 220 9.198e-05 0.0008246
520 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 4 37 9.251e-05 0.0008262
521 REGULATION OF RECEPTOR INTERNALIZATION 4 37 9.251e-05 0.0008262
522 REGULATION OF BINDING 9 283 9.334e-05 0.000832
523 CYTOSKELETON ORGANIZATION 16 838 9.966e-05 0.0008866
524 REGULATION OF TRANSMEMBRANE TRANSPORT 11 426 0.0001007 0.0008945
525 RESPONSE TO CALCIUM ION 6 115 0.0001015 0.0008995
526 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 4 38 0.0001029 0.0009083
527 POSITIVE REGULATION OF ORGAN GROWTH 4 38 0.0001029 0.0009083
528 POSITIVE REGULATION OF STAT CASCADE 5 73 0.0001092 0.0009604
529 POSITIVE REGULATION OF JAK STAT CASCADE 5 73 0.0001092 0.0009604
530 APOPTOTIC SIGNALING PATHWAY 9 289 0.0001094 0.0009608
531 REGULATION OF SYSTEM PROCESS 12 507 0.0001103 0.0009663
532 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 6 117 0.0001116 0.0009764
533 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 3 15 0.0001127 0.0009802
534 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 3 15 0.0001127 0.0009802
535 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 3 15 0.0001127 0.0009802
536 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 39 0.0001141 0.0009902
537 REGULATION OF DEFENSE RESPONSE 15 759 0.0001143 0.0009904
538 TELENCEPHALON DEVELOPMENT 8 228 0.0001178 0.001019
539 GLUCOSE HOMEOSTASIS 7 170 0.0001186 0.001022
540 CARBOHYDRATE HOMEOSTASIS 7 170 0.0001186 0.001022
541 REGULATION OF ION TRANSPORT 13 592 0.0001198 0.00103
542 CELLULAR HOMEOSTASIS 14 676 0.0001204 0.001033
543 TISSUE HOMEOSTASIS 7 171 0.0001231 0.001054
544 MUSCLE CONTRACTION 8 233 0.0001368 0.00117
545 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.0001381 0.001177
546 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 3 16 0.0001381 0.001177
547 POSITIVE REGULATION OF SECRETION 10 370 0.0001454 0.001237
548 RESPONSE TO CORTICOSTEROID 7 176 0.0001471 0.001249
549 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 78 0.0001496 0.001268
550 REGULATION OF HEART GROWTH 4 42 0.0001529 0.001294
551 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 6 124 0.0001536 0.001297
552 NEGATIVE REGULATION OF CELL DEVELOPMENT 9 303 0.0001563 0.001317
553 CELLULAR RESPONSE TO STRESS 23 1565 0.0001574 0.001324
554 RESPONSE TO BACTERIUM 12 528 0.0001609 0.001352
555 NEGATIVE REGULATION OF PLATELET ACTIVATION 3 17 0.0001669 0.001391
556 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 3 17 0.0001669 0.001391
557 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 3 17 0.0001669 0.001391
558 NEGATIVE REGULATION OF ANOIKIS 3 17 0.0001669 0.001391
559 MYELOID LEUKOCYTE MEDIATED IMMUNITY 4 43 0.0001678 0.001394
560 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 4 43 0.0001678 0.001394
561 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 0.0001788 0.001483
562 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 4 44 0.0001836 0.00152
563 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 0.0001872 0.001544
564 REGULATION OF PROTEIN IMPORT 7 183 0.0001872 0.001544
565 NEGATIVE REGULATION OF TRANSPORT 11 458 0.0001896 0.001558
566 IN UTERO EMBRYONIC DEVELOPMENT 9 311 0.0001898 0.001558
567 POSITIVE REGULATION OF CELL ACTIVATION 9 311 0.0001898 0.001558
568 REGULATION OF COLLATERAL SPROUTING 3 18 0.0001993 0.001633
569 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.0002005 0.00164
570 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 12 541 0.0002014 0.001641
571 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 12 541 0.0002014 0.001641
572 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 0.0002038 0.001658
573 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 6 131 0.0002073 0.001683
574 REGULATION OF AUTOPHAGY 8 249 0.0002153 0.001745
575 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 6 133 0.0002251 0.001818
576 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 6 133 0.0002251 0.001818
577 REGULATION OF CELL GROWTH 10 391 0.0002269 0.00183
578 MESENCHYMAL CELL DIFFERENTIATION 6 134 0.0002344 0.001887
579 PHAGOCYTOSIS 7 190 0.0002355 0.001893
580 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 5 86 0.0002368 0.0019
581 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 4 47 0.0002377 0.001904
582 IMMUNE RESPONSE 18 1100 0.0002479 0.001982
583 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 17 1004 0.0002514 0.002007
584 GLIAL CELL DIFFERENTIATION 6 136 0.0002539 0.002023
585 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.000258 0.002049
586 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 4 48 0.000258 0.002049
587 REGULATION OF COAGULATION 5 88 0.0002637 0.00209
588 EYE DEVELOPMENT 9 326 0.000269 0.002129
589 PLACENTA DEVELOPMENT 6 138 0.0002747 0.00217
590 MICROVILLUS ORGANIZATION 3 20 0.0002758 0.002175
591 B CELL DIFFERENTIATION 5 89 0.0002779 0.002188
592 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 4 49 0.0002795 0.002197
593 ENDOTHELIUM DEVELOPMENT 5 90 0.0002928 0.002293
594 MESONEPHROS DEVELOPMENT 5 90 0.0002928 0.002293
595 NON CANONICAL WNT SIGNALING PATHWAY 6 140 0.0002969 0.002321
596 REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 50 0.0003023 0.002356
597 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.0003023 0.002356
598 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 262 0.0003035 0.002361
599 CELL PROJECTION ASSEMBLY 8 264 0.0003193 0.00248
600 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 0.0003202 0.002484
601 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 6 144 0.0003453 0.002673
602 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 7 203 0.0003519 0.00272
603 PROTEIN LOCALIZATION TO CELL SURFACE 3 22 0.0003691 0.002838
604 ACTIVATION OF PROTEIN KINASE B ACTIVITY 3 22 0.0003691 0.002838
605 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 3 22 0.0003691 0.002838
606 LYMPHOCYTE ACTIVATION 9 342 0.0003819 0.002932
607 REGULATION OF T CELL PROLIFERATION 6 147 0.0003855 0.002955
608 DIVALENT INORGANIC CATION HOMEOSTASIS 9 343 0.00039 0.002985
609 POSITIVE REGULATION OF CELL GROWTH 6 148 0.0003997 0.003054
610 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 4 54 0.000407 0.003105
611 REGULATION OF LEUKOCYTE MIGRATION 6 149 0.0004143 0.003145
612 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 5 97 0.0004142 0.003145
613 NEUROMUSCULAR PROCESS 5 97 0.0004142 0.003145
614 MUSCLE TISSUE DEVELOPMENT 8 275 0.0004192 0.003176
615 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.0004224 0.003191
616 REGULATION OF METANEPHROS DEVELOPMENT 3 23 0.0004224 0.003191
617 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 7 211 0.0004439 0.003337
618 SKIN DEVELOPMENT 7 211 0.0004439 0.003337
619 MULTICELLULAR ORGANISM REPRODUCTION 14 768 0.0004426 0.003337
620 MYELOID LEUKOCYTE MIGRATION 5 99 0.000455 0.003409
621 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 99 0.000455 0.003409
622 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 0.0004606 0.00344
623 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 6 152 0.0004606 0.00344
624 INOSITOL PHOSPHATE METABOLIC PROCESS 4 56 0.000468 0.003484
625 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 56 0.000468 0.003484
626 RESPONSE TO OXIDATIVE STRESS 9 352 0.0004704 0.003497
627 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 153 0.0004769 0.003534
628 LIMBIC SYSTEM DEVELOPMENT 5 100 0.0004765 0.003534
629 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0004805 0.003538
630 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0004805 0.003538
631 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 0.0004805 0.003538
632 REGULATION OF ANOIKIS 3 24 0.0004805 0.003538
633 RESPONSE TO DRUG 10 431 0.0004894 0.003597
634 PROTEIN LOCALIZATION 24 1805 0.0004929 0.003617
635 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 282 0.000495 0.003627
636 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.0004987 0.003649
637 NEGATIVE REGULATION OF WOUND HEALING 4 58 0.0005353 0.00391
638 REGULATION OF CALCIUM ION IMPORT 5 103 0.0005456 0.003979
639 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 9 360 0.0005529 0.004026
640 POSITIVE REGULATION OF PROTEIN IMPORT 5 104 0.0005702 0.004145
641 REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 363 0.0005868 0.004259
642 RESPONSE TO BIOTIC STIMULUS 15 886 0.0005949 0.004311
643 POSITIVE REGULATION OF DEFENSE RESPONSE 9 364 0.0005984 0.00433
644 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0006115 0.004391
645 REGULATION OF MONOOXYGENASE ACTIVITY 4 60 0.0006092 0.004391
646 STEM CELL PROLIFERATION 4 60 0.0006092 0.004391
647 REGULATION OF P38MAPK CASCADE 3 26 0.0006115 0.004391
648 REGULATION OF CELL FATE COMMITMENT 3 26 0.0006115 0.004391
649 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 5 106 0.0006219 0.004459
650 POSITIVE REGULATION OF LYASE ACTIVITY 4 61 0.0006487 0.004636
651 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 4 61 0.0006487 0.004636
652 REGULATION OF NUCLEAR DIVISION 6 163 0.0006659 0.004745
653 VASCULAR PROCESS IN CIRCULATORY SYSTEM 6 163 0.0006659 0.004745
654 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 5 109 0.000706 0.005016
655 RESPONSE TO HYDROGEN PEROXIDE 5 109 0.000706 0.005016
656 REGULATION OF OSTEOCLAST DIFFERENTIATION 4 63 0.0007331 0.0052
657 EMBRYONIC MORPHOGENESIS 11 539 0.0007464 0.005286
658 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 3 28 0.0007632 0.005373
659 REGULATION OF NEUROBLAST PROLIFERATION 3 28 0.0007632 0.005373
660 MAMMARY GLAND DUCT MORPHOGENESIS 3 28 0.0007632 0.005373
661 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 3 28 0.0007632 0.005373
662 ALCOHOL BIOSYNTHETIC PROCESS 5 111 0.0007667 0.005389
663 REGULATION OF CYTOKINESIS 4 64 0.0007781 0.005461
664 REGULATION OF PROTEIN BINDING 6 168 0.0007799 0.005465
665 SINGLE ORGANISM CELL ADHESION 10 459 0.0007945 0.005559
666 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 7 233 0.0007987 0.00558
667 NEGATIVE REGULATION OF AXONOGENESIS 4 65 0.000825 0.005755
668 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 9 381 0.0008273 0.005763
669 REGULATION OF SYNAPSE ORGANIZATION 5 113 0.0008311 0.00578
670 EPIDERMIS MORPHOGENESIS 3 29 0.0008473 0.005858
671 POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 3 29 0.0008473 0.005858
672 NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 3 29 0.0008473 0.005858
673 NEUROBLAST PROLIFERATION 3 29 0.0008473 0.005858
674 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 6 171 0.0008551 0.005904
675 POSITIVE REGULATION OF ENDOCYTOSIS 5 114 0.0008648 0.005961
676 ACID SECRETION 4 66 0.0008739 0.005998
677 FOREBRAIN GENERATION OF NEURONS 4 66 0.0008739 0.005998
678 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 4 66 0.0008739 0.005998
679 REGULATION OF CATABOLIC PROCESS 13 731 0.0008947 0.006131
680 STRIATED MUSCLE CELL DIFFERENTIATION 6 173 0.0009084 0.006216
681 SENSORY ORGAN MORPHOGENESIS 7 239 0.0009267 0.006331
682 DEFENSE RESPONSE 18 1231 0.0009353 0.006365
683 NEGATIVE REGULATION OF CELL MATRIX ADHESION 3 30 0.000937 0.006365
684 PHOSPHOLIPID CATABOLIC PROCESS 3 30 0.000937 0.006365
685 OSTEOCLAST DIFFERENTIATION 3 30 0.000937 0.006365
686 CELLULAR MACROMOLECULE LOCALIZATION 18 1234 0.0009616 0.006523
687 GLIOGENESIS 6 175 0.0009641 0.00653
688 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.000972 0.006564
689 LEUKOCYTE CHEMOTAXIS 5 117 0.000972 0.006564
690 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 4 68 0.0009777 0.006593
691 REGULATION OF CELL CYCLE PROCESS 11 558 0.0009892 0.006661
692 BIOLOGICAL ADHESION 16 1032 0.0009972 0.006705
693 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 23 1784 0.001001 0.006721
694 REGULATION OF OSSIFICATION 6 178 0.001053 0.007057
695 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 6 179 0.001083 0.007253
696 REGULATION OF ADENYLATE CYCLASE ACTIVITY 4 70 0.00109 0.007266
697 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 4 70 0.00109 0.007266
698 REGULATION OF DENDRITE DEVELOPMENT 5 120 0.001089 0.007266
699 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 121 0.00113 0.007521
700 REGULATION OF ORGAN FORMATION 3 32 0.001134 0.007527
701 METANEPHRIC NEPHRON DEVELOPMENT 3 32 0.001134 0.007527
702 T CELL DIFFERENTIATION 5 123 0.001216 0.008057
703 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 3 33 0.001242 0.008218
704 REGULATION OF ORGAN GROWTH 4 73 0.001275 0.008414
705 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 73 0.001275 0.008414
706 SINGLE ORGANISM CATABOLIC PROCESS 15 957 0.001296 0.00854
707 KIDNEY EPITHELIUM DEVELOPMENT 5 125 0.001306 0.008595
708 EPITHELIAL CELL DEVELOPMENT 6 186 0.001319 0.00867
709 FOREBRAIN NEURON DEVELOPMENT 3 34 0.001355 0.008895
710 REGULATION OF PEPTIDE TRANSPORT 7 256 0.001378 0.009033
711 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 5 127 0.001401 0.00915
712 POSITIVE REGULATION OF BINDING 5 127 0.001401 0.00915
713 EPITHELIAL CELL DIFFERENTIATION 10 495 0.001402 0.00915
714 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 4 75 0.00141 0.009173
715 CELLULAR GLUCOSE HOMEOSTASIS 4 75 0.00141 0.009173
716 RESPONSE TO METAL ION 8 333 0.001447 0.009407
717 HEPATICOBILIARY SYSTEM DEVELOPMENT 5 128 0.001451 0.009415
718 REGULATION OF CALCIUM MEDIATED SIGNALING 4 76 0.00148 0.009541
719 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 4 76 0.00148 0.009541
720 MULTICELLULAR ORGANISM GROWTH 4 76 0.00148 0.009541
721 REGULATION OF GLYCOGEN METABOLIC PROCESS 3 35 0.001476 0.009541
722 RESPONSE TO MINERALOCORTICOID 3 35 0.001476 0.009541
723 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 5 129 0.001502 0.009664
724 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 6 191 0.00151 0.009693
725 RESPONSE TO REACTIVE OXYGEN SPECIES 6 191 0.00151 0.009693
726 DEVELOPMENTAL CELL GROWTH 4 77 0.001554 0.009959
NumGOOverlapSizeP ValueAdj. P Value
1 KINASE ACTIVITY 50 842 3.121e-35 2.9e-32
2 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 22 70 6.561e-32 2.399e-29
3 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 50 992 7.748e-32 2.399e-29
4 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 30 228 5.464e-31 1.269e-28
5 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 31 303 1.425e-28 2.067e-26
6 MOLECULAR FUNCTION REGULATOR 53 1353 1.558e-28 2.067e-26
7 RECEPTOR BINDING 55 1476 1.183e-28 2.067e-26
8 PROTEIN TYROSINE KINASE ACTIVITY 26 176 3.09e-28 3.588e-26
9 GROWTH FACTOR ACTIVITY 25 160 8.368e-28 8.638e-26
10 PROTEIN KINASE ACTIVITY 38 640 2.463e-26 2.288e-24
11 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 2.08e-23 1.756e-21
12 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 15 43 7.824e-23 6.057e-21
13 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 1.577e-21 1.127e-19
14 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 17 81 1.769e-21 1.174e-19
15 GROWTH FACTOR RECEPTOR BINDING 17 129 7.557e-18 4.68e-16
16 SIGNAL TRANSDUCER ACTIVITY 44 1731 4.557e-16 2.646e-14
17 GROWTH FACTOR BINDING 15 123 2.356e-15 1.287e-13
18 RIBONUCLEOTIDE BINDING 43 1860 3.192e-14 1.648e-12
19 ENZYME BINDING 40 1737 3.924e-13 1.919e-11
20 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 7 15 2.429e-12 1.128e-10
21 ENZYME ACTIVATOR ACTIVITY 21 471 2.93e-12 1.296e-10
22 CHEMOATTRACTANT ACTIVITY 8 27 4.817e-12 2.034e-10
23 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 8 28 6.708e-12 2.597e-10
24 KINASE BINDING 23 606 6.526e-12 2.597e-10
25 PHOSPHOLIPASE A2 ACTIVITY 8 31 1.675e-11 6.225e-10
26 HEPARIN BINDING 13 157 2.797e-11 9.996e-10
27 PROTEIN TYROSINE KINASE BINDING 9 54 6.064e-11 2.087e-09
28 ADENYL NUCLEOTIDE BINDING 33 1514 3.314e-10 1.099e-08
29 SULFUR COMPOUND BINDING 14 234 3.621e-10 1.16e-08
30 PHOSPHOLIPASE ACTIVITY 10 94 5.006e-10 1.55e-08
31 GLYCOSAMINOGLYCAN BINDING 13 205 7.815e-10 2.342e-08
32 RECEPTOR SIGNALING PROTEIN ACTIVITY 12 172 1.218e-09 3.536e-08
33 ENZYME REGULATOR ACTIVITY 25 959 2.033e-09 5.723e-08
34 LIPASE ACTIVITY 10 117 4.359e-09 1.191e-07
35 INSULIN RECEPTOR SUBSTRATE BINDING 5 11 4.625e-09 1.228e-07
36 NEUROTROPHIN RECEPTOR BINDING 5 14 1.973e-08 5.092e-07
37 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 3.35e-08 8.411e-07
38 GTPASE ACTIVITY 12 246 6.733e-08 1.646e-06
39 PROTEIN COMPLEX BINDING 22 935 1.313e-07 3.127e-06
40 KINASE ACTIVATOR ACTIVITY 7 62 1.444e-07 3.353e-06
41 CARBOXYLIC ESTER HYDROLASE ACTIVITY 9 135 2.299e-07 5.21e-06
42 PROTEIN DIMERIZATION ACTIVITY 24 1149 2.934e-07 6.49e-06
43 KINASE REGULATOR ACTIVITY 10 186 3.589e-07 7.754e-06
44 DIACYLGLYCEROL BINDING 4 11 5.263e-07 1.087e-05
45 PLATELET DERIVED GROWTH FACTOR BINDING 4 11 5.263e-07 1.087e-05
46 IDENTICAL PROTEIN BINDING 24 1209 7.337e-07 1.482e-05
47 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 12 329 1.506e-06 2.914e-05
48 CYTOKINE RECEPTOR BINDING 11 271 1.496e-06 2.914e-05
49 THIOESTERASE BINDING 4 14 1.573e-06 2.982e-05
50 INSULIN RECEPTOR BINDING 5 32 1.808e-06 3.36e-05
51 PROTEIN HETERODIMERIZATION ACTIVITY 14 468 2.039e-06 3.714e-05
52 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 4 15 2.134e-06 3.812e-05
53 PROTEIN HOMODIMERIZATION ACTIVITY 17 722 4.046e-06 7.091e-05
54 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 4 19 5.939e-06 0.0001022
55 PROTEIN SERINE THREONINE KINASE ACTIVITY 13 445 6.234e-06 0.0001053
56 MACROMOLECULAR COMPLEX BINDING 24 1399 9.173e-06 0.0001522
57 PROTEIN PHOSPHATASE BINDING 7 120 1.282e-05 0.0002089
58 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 6 92 2.902e-05 0.0004648
59 PHOSPHATIDYLCHOLINE 1 ACYLHYDROLASE ACTIVITY 3 11 4.165e-05 0.0006558
60 GUANYL NUCLEOTIDE BINDING 11 390 4.581e-05 0.0007093
61 SIGNALING RECEPTOR ACTIVITY 22 1393 7.933e-05 0.001208
62 PHOSPHATASE BINDING 7 162 8.779e-05 0.001315
63 MAP KINASE ACTIVITY 3 14 9.059e-05 0.001336
64 SIGNALING ADAPTOR ACTIVITY 5 74 0.0001165 0.001691
65 RECEPTOR ACTIVITY 24 1649 0.0001285 0.001836
66 GTP DEPENDENT PROTEIN BINDING 3 17 0.0001669 0.002349
67 PHOSPHOLIPASE BINDING 3 19 0.0002355 0.003266
68 EPHRIN RECEPTOR BINDING 3 24 0.0004805 0.006565
69 PROTEIN DOMAIN SPECIFIC BINDING 12 624 0.0007232 0.009736
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOPLASMIC SIDE OF MEMBRANE 21 170 3.116e-21 1.819e-18
2 SIDE OF MEMBRANE 24 428 4.226e-16 1.234e-13
3 EXTRINSIC COMPONENT OF MEMBRANE 17 252 5.973e-13 1.163e-10
4 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 12 98 1.564e-12 2.284e-10
5 INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE 7 15 2.429e-12 2.837e-10
6 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 12 136 7.947e-11 7.735e-09
7 VESICLE LUMEN 10 106 1.652e-09 1.379e-07
8 PLATELET ALPHA GRANULE LUMEN 8 55 2.272e-09 1.658e-07
9 INTRINSIC COMPONENT OF PLASMA MEMBRANE 33 1649 2.905e-09 1.885e-07
10 PLATELET ALPHA GRANULE 8 75 2.826e-08 1.651e-06
11 EXTRACELLULAR SPACE 28 1376 4.271e-08 2.268e-06
12 SECRETORY VESICLE 16 461 4.799e-08 2.272e-06
13 HETEROTRIMERIC G PROTEIN COMPLEX 6 32 5.059e-08 2.272e-06
14 SECRETORY GRANULE LUMEN 8 85 7.64e-08 3.187e-06
15 INTRACELLULAR VESICLE 26 1259 1.071e-07 4.17e-06
16 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 5 20 1.481e-07 5.407e-06
17 CELL JUNCTION 24 1151 3.028e-07 1.04e-05
18 SECRETORY GRANULE 13 352 4.678e-07 1.518e-05
19 CELL SURFACE 18 757 1.784e-06 5.484e-05
20 MEMBRANE MICRODOMAIN 11 288 2.697e-06 7.877e-05
21 PLASMA MEMBRANE PROTEIN COMPLEX 14 510 5.494e-06 0.0001528
22 RECEPTOR COMPLEX 11 327 9.033e-06 0.0002306
23 MAST CELL GRANULE 4 21 9.08e-06 0.0002306
24 MEMBRANE REGION 21 1134 1.162e-05 0.0002827
25 PERINUCLEAR REGION OF CYTOPLASM 15 642 1.708e-05 0.0003991
26 MEMBRANE PROTEIN COMPLEX 19 1020 2.943e-05 0.0006611
27 CELL SUBSTRATE JUNCTION 11 398 5.5e-05 0.00119
28 CELL LEADING EDGE 10 350 9.229e-05 0.001925
29 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 8 237 0.0001537 0.003096
30 PLASMA MEMBRANE REGION 16 929 0.0003207 0.006242
31 ANCHORING JUNCTION 11 489 0.0003319 0.006253
32 NEURONAL POSTSYNAPTIC DENSITY 4 53 0.0003787 0.006912
33 SITE OF POLARIZED GROWTH 6 149 0.0004143 0.007263
34 CELL PROJECTION 24 1786 0.0004229 0.007263
35 CYTOPLASMIC VESICLE PART 12 601 0.00052 0.008676
36 VACUOLE 18 1180 0.0005732 0.009299

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04014_Ras_signaling_pathway 129 236 2.278e-268 4.1e-266
2 hsa04151_PI3K_AKT_signaling_pathway 70 351 1.152e-89 1.037e-87
3 hsa04010_MAPK_signaling_pathway 56 268 2.11e-71 1.266e-69
4 hsa04510_Focal_adhesion 39 200 1.58e-47 7.109e-46
5 hsa04810_Regulation_of_actin_cytoskeleton 37 214 6.054e-43 2.18e-41
6 hsa04722_Neurotrophin_signaling_pathway 30 127 3.753e-39 1.126e-37
7 hsa04664_Fc_epsilon_RI_signaling_pathway 26 79 3.031e-38 7.795e-37
8 hsa04370_VEGF_signaling_pathway 23 76 6.82e-33 1.535e-31
9 hsa04062_Chemokine_signaling_pathway 29 189 5.682e-32 1.136e-30
10 hsa04012_ErbB_signaling_pathway 23 87 2.428e-31 4.371e-30
11 hsa04912_GnRH_signaling_pathway 22 101 6.108e-28 9.994e-27
12 hsa04660_T_cell_receptor_signaling_pathway 18 108 9.388e-21 1.408e-19
13 hsa04662_B_cell_receptor_signaling_pathway 16 75 2.135e-20 2.957e-19
14 hsa04910_Insulin_signaling_pathway 19 138 3.289e-20 4.229e-19
15 hsa04650_Natural_killer_cell_mediated_cytotoxicity 18 136 7.091e-19 8.51e-18
16 hsa04730_Long.term_depression 14 70 1.49e-17 1.676e-16
17 hsa04540_Gap_junction 15 90 1.837e-17 1.945e-16
18 hsa04666_Fc_gamma_R.mediated_phagocytosis 15 95 4.31e-17 4.31e-16
19 hsa04914_Progesterone.mediated_oocyte_maturation 14 87 3.805e-16 3.605e-15
20 hsa04380_Osteoclast_differentiation 15 128 4.323e-15 3.89e-14
21 hsa04720_Long.term_potentiation 12 70 2.385e-14 1.968e-13
22 hsa04270_Vascular_smooth_muscle_contraction 14 116 2.436e-14 1.968e-13
23 hsa04150_mTOR_signaling_pathway 11 52 2.514e-14 1.968e-13
24 hsa04670_Leukocyte_transendothelial_migration 14 117 2.752e-14 2.064e-13
25 hsa04960_Aldosterone.regulated_sodium_reabsorption 10 42 1.08e-13 7.778e-13
26 hsa04972_Pancreatic_secretion 12 101 2.258e-12 1.563e-11
27 hsa00592_alpha.Linolenic_acid_metabolism 7 20 2.849e-11 1.899e-10
28 hsa04360_Axon_guidance 12 130 4.665e-11 2.999e-10
29 hsa04620_Toll.like_receptor_signaling_pathway 11 102 5.652e-11 3.508e-10
30 hsa04070_Phosphatidylinositol_signaling_system 10 78 7.599e-11 4.559e-10
31 hsa04320_Dorso.ventral_axis_formation 7 25 1.72e-10 9.986e-10
32 hsa04210_Apoptosis 10 89 2.893e-10 1.627e-09
33 hsa00591_Linoleic_acid_metabolism 7 30 7.092e-10 3.868e-09
34 hsa04916_Melanogenesis 10 101 1.024e-09 5.422e-09
35 hsa04020_Calcium_signaling_pathway 12 177 1.691e-09 8.697e-09
36 hsa00565_Ether_lipid_metabolism 7 36 2.816e-09 1.408e-08
37 hsa04144_Endocytosis 12 203 7.994e-09 3.889e-08
38 hsa04973_Carbohydrate_digestion_and_absorption 7 44 1.239e-08 5.867e-08
39 hsa04975_Fat_digestion_and_absorption 7 46 1.712e-08 7.9e-08
40 hsa04520_Adherens_junction 8 73 2.276e-08 1.024e-07
41 hsa04630_Jak.STAT_signaling_pathway 10 155 6.521e-08 2.863e-07
42 hsa00590_Arachidonic_acid_metabolism 7 59 1.018e-07 4.362e-07
43 hsa04530_Tight_junction 9 133 2.024e-07 8.471e-07
44 hsa00564_Glycerophospholipid_metabolism 7 80 8.472e-07 3.466e-06
45 hsa04920_Adipocytokine_signaling_pathway 6 68 5.054e-06 2.022e-05
46 hsa04310_Wnt_signaling_pathway 8 151 6.179e-06 2.418e-05
47 hsa04114_Oocyte_meiosis 6 114 9.67e-05 0.0003703
48 hsa04971_Gastric_acid_secretion 5 74 0.0001165 0.0004369
49 hsa04640_Hematopoietic_cell_lineage 5 88 0.0002637 0.0009686
50 hsa04970_Salivary_secretion 5 89 0.0002779 0.001001
51 hsa04621_NOD.like_receptor_signaling_pathway 4 59 0.0005714 0.002017
52 hsa04622_RIG.I.like_receptor_signaling_pathway 4 71 0.001149 0.003978
53 hsa00562_Inositol_phosphate_metabolism 3 57 0.005951 0.02021
54 hsa04744_Phototransduction 2 29 0.01496 0.04986
55 hsa04141_Protein_processing_in_endoplasmic_reticulum 3 168 0.09494 0.3107
56 hsa04740_Olfactory_transduction 3 388 0.4585 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 29 IGF1 Sponge network 1.057 0.31716 0.009 0.98747 0.587
2

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 14 GNB4 Sponge network 0.551 0.56177 0.151 0.87091 0.586
3

CECR7

 hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 24 PRKCB Sponge network 0.551 0.56177 -0.289 0.6299 0.583
4

CECR7

 hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-652-3p;hsa-miR-7-1-3p 21 MRAS Sponge network 0.551 0.56177 0.229 0.7586 0.582
5

CECR7

 hsa-miR-10a-5p;hsa-miR-1180-3p;hsa-miR-1275;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148b-5p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-30c-5p;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-502-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-942-5p 26 ETS1 Sponge network 0.551 0.56177 -0.02 0.98857 0.578
6

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-484;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 23 FGF7 Sponge network 1.057 0.31716 0.117 0.8481 0.575
7

EMX2OS

 hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-7-1-3p 22 MRAS Sponge network 1.057 0.31716 0.229 0.7586 0.574
8

EMX2OS

 hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-374a-3p;hsa-miR-484;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-7-5p;hsa-miR-760 16 FGF1 Sponge network 1.057 0.31716 0.817 0.03603 0.558
9

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 25 AKT3 Sponge network 1.057 0.31716 0.457 0.53933 0.542
10

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 18 FGF7 Sponge network 0.551 0.56177 0.117 0.8481 0.536
11

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 1.057 0.31716 0.202 0.85898 0.535
12

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-532-5p;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 0.551 0.56177 0.202 0.85898 0.531
13

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-21-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 13 GNB4 Sponge network 1.057 0.31716 0.151 0.87091 0.528
14

MEG3

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 13 FGF7 Sponge network 0.433 0.33816 0.117 0.8481 0.524
15

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-224-5p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-92a-3p 23 GRIN2A Sponge network 1.057 0.31716 0.268 0.78845 0.52
16

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p 24 IGF1 Sponge network 0.551 0.56177 0.009 0.98747 0.513
17

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-93-5p 20 AKT3 Sponge network 0.551 0.56177 0.457 0.53933 0.508
18

CECR7

 hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p 13 MAPK10 Sponge network 0.551 0.56177 0.278 0.49976 0.504
19

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-532-3p;hsa-miR-532-5p;hsa-miR-93-5p;hsa-miR-939-5p 21 CSF1 Sponge network 0.551 0.56177 -0.253 0.7772 0.495
20

EMX2OS

 hsa-miR-10a-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-185-3p;hsa-miR-188-3p;hsa-miR-194-3p;hsa-miR-27a-3p;hsa-miR-30b-3p;hsa-miR-324-5p;hsa-miR-335-5p;hsa-miR-625-5p;hsa-miR-760 12 NGFR Sponge network 1.057 0.31716 0.885 0.10912 0.495
21

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-7-1-3p;hsa-miR-96-5p 15 MRAS Sponge network 0.433 0.33816 0.229 0.7586 0.487
22

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-224-5p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-7-1-3p 22 GRIN2A Sponge network 0.551 0.56177 0.268 0.78845 0.486
23

CECR7

 hsa-miR-1275;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-760 16 FGF1 Sponge network 0.551 0.56177 0.817 0.03603 0.477
24

CECR7

 hsa-miR-10a-5p;hsa-miR-1275;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-188-3p;hsa-miR-194-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-760 10 NGFR Sponge network 0.551 0.56177 0.885 0.10912 0.476
25

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 0.551 0.56177 0.313 0.74314 0.471
26

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-375;hsa-miR-421;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 11 PDGFC Sponge network 1.057 0.31716 0.414 0.61683 0.457
27

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 31 PDGFRA Sponge network 0.551 0.56177 -0.146 0.90295 0.453
28

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 13 FGFR1 Sponge network 0.433 0.33816 0.202 0.85898 0.452
29

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-651-5p;hsa-miR-7-1-3p 16 HGF Sponge network 0.551 0.56177 -0.215 0.64343 0.452
30

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-144-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-582-3p;hsa-miR-625-5p;hsa-miR-642a-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-93-5p 23 RGL1 Sponge network 1.057 0.31716 0.251 0.76605 0.449
31

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30c-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 20 RGL1 Sponge network 0.551 0.56177 0.251 0.76605 0.43
32

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 18 FLT1 Sponge network 0.551 0.56177 0.335 0.76965 0.415
33

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 27 FGF2 Sponge network 0.551 0.56177 0.037 0.94566 0.412
34

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-454-3p;hsa-miR-505-3p;hsa-miR-532-3p;hsa-miR-93-5p;hsa-miR-939-5p;hsa-miR-940 22 CSF1 Sponge network 1.057 0.31716 -0.253 0.7772 0.412
35

CECR7

 hsa-miR-1275;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-3p;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-29b-3p;hsa-miR-378a-3p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-671-5p;hsa-miR-939-5p 16 GNG7 Sponge network 0.551 0.56177 0.247 0.54778 0.41
36

EMX2OS

 hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-940 12 MAPK10 Sponge network 1.057 0.31716 0.278 0.49976 0.408
37

EMX2OS

 hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-452-3p;hsa-miR-484;hsa-miR-502-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 21 PRKCB Sponge network 1.057 0.31716 -0.289 0.6299 0.407
38

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 12 AKT3 Sponge network 0.433 0.33816 0.457 0.53933 0.405
39

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 18 FLT1 Sponge network 1.057 0.31716 0.335 0.76965 0.399
40

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 21 PDGFRA Sponge network 0.433 0.33816 -0.146 0.90295 0.397
41

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-135b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-592;hsa-miR-93-5p 20 TIAM1 Sponge network 0.551 0.56177 -0.038 0.94118 0.394
42

CECR7

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-760 21 NTRK2 Sponge network 0.551 0.56177 0.714 0.34423 0.38
43

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-939-5p;hsa-miR-96-5p 15 CSF1 Sponge network 0.433 0.33816 -0.253 0.7772 0.379
44

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-627-5p 14 FGF12 Sponge network 1.057 0.31716 -0.073 0.90082 0.377
45

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-1266-5p;hsa-miR-128-3p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-324-5p;hsa-miR-378a-3p;hsa-miR-505-3p;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-744-3p;hsa-miR-93-5p 31 ABL2 Sponge network 1.057 0.31716 0.257 0.81476 0.376
46

MEG3

 hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-374b-3p;hsa-miR-576-5p;hsa-miR-577 10 IGF1 Sponge network 0.433 0.33816 0.009 0.98747 0.37
47

CECR7

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 PIK3CA Sponge network 0.551 0.56177 0.023 0.97942 0.368
48

EMX2OS

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-3p;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-29b-3p;hsa-miR-378a-3p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-671-5p;hsa-miR-92a-3p;hsa-miR-939-5p;hsa-miR-940 18 GNG7 Sponge network 1.057 0.31716 0.247 0.54778 0.368
49

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-671-5p 17 KIT Sponge network 0.551 0.56177 0.458 0.49662 0.357
50

EMX2OS

 hsa-miR-10a-5p;hsa-miR-1180-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148b-5p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-502-5p;hsa-miR-532-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-940;hsa-miR-942-5p 27 ETS1 Sponge network 1.057 0.31716 -0.02 0.98857 0.356
51

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-7-1-3p 11 HGF Sponge network 1.057 0.31716 -0.215 0.64343 0.353
52

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-135b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-93-3p;hsa-miR-93-5p 19 TIAM1 Sponge network 1.057 0.31716 -0.038 0.94118 0.349
53

ZNF883

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-582-5p 15 MRAS Sponge network 0.913 0.16772 0.229 0.7586 0.344
54

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-374a-3p;hsa-miR-374b-5p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p 36 FGF2 Sponge network 1.057 0.31716 0.037 0.94566 0.343
55

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-642a-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 35 PDGFRA Sponge network 1.057 0.31716 -0.146 0.90295 0.34
56

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-16-2-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-582-3p;hsa-miR-590-5p 10 FGF7 Sponge network 0.913 0.16772 0.117 0.8481 0.339
57

CECR7

 hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-20a-3p;hsa-miR-324-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 12 SHC4 Sponge network 0.551 0.56177 0.573 0.21799 0.333
58

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 15 RGL1 Sponge network 0.433 0.33816 0.251 0.76605 0.332
59

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-671-5p 19 KIT Sponge network 1.057 0.31716 0.458 0.49662 0.331
60

HCG11

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-1266-5p;hsa-miR-128-3p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-26a-1-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-7-1-3p;hsa-miR-744-3p 19 ABL2 Sponge network 0.419 0.63279 0.257 0.81476 0.327
61

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-128-3p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 26 ABL2 Sponge network 0.551 0.56177 0.257 0.81476 0.322
62

MEG3

 hsa-miR-151a-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-20a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-5p;hsa-miR-96-5p 11 SHC4 Sponge network 0.433 0.33816 0.573 0.21799 0.314
63

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 1.057 0.31716 0.313 0.74314 0.304
64

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-33a-3p 10 AKT3 Sponge network 0.913 0.16772 0.457 0.53933 0.3
65

MEG3

 hsa-miR-146a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-577;hsa-miR-590-5p 16 FGF2 Sponge network 0.433 0.33816 0.037 0.94566 0.296
66

CECR7

 hsa-miR-1262;hsa-miR-1304-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-194-3p;hsa-miR-19b-1-5p;hsa-miR-200a-3p;hsa-miR-502-5p;hsa-miR-590-3p 11 RASA4 Sponge network 0.551 0.56177 0.085 0.90642 0.291
67

MEG3

 hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-146a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-625-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 24 ABL2 Sponge network 0.433 0.33816 0.257 0.81476 0.29
68

EMX2OS

 hsa-miR-1262;hsa-miR-1304-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-194-3p;hsa-miR-19b-1-5p;hsa-miR-200a-3p;hsa-miR-452-3p;hsa-miR-502-5p;hsa-miR-590-3p;hsa-miR-940 13 RASA4 Sponge network 1.057 0.31716 0.085 0.90642 0.288
69 AGAP11 hsa-miR-1266-5p;hsa-miR-128-3p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-576-5p;hsa-miR-93-5p 10 ABL2 Sponge network 0.427 0.38172 0.257 0.81476 0.285
70

EMX2OS

 hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-324-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p 12 SHC4 Sponge network 1.057 0.31716 0.573 0.21799 0.28
71

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-627-5p 13 FGF12 Sponge network 0.551 0.56177 -0.073 0.90082 0.278
72

CECR7

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 14 BDNF Sponge network 0.551 0.56177 0.503 0.16933 0.274
73

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p 15 IGF1 Sponge network 0.913 0.16772 0.009 0.98747 0.269
74

EMX2OS

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-760;hsa-miR-940 25 NTRK2 Sponge network 1.057 0.31716 0.714 0.34423 0.268
75

MEG3

 hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29b-1-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-7-1-3p 14 PRKCB Sponge network 0.433 0.33816 -0.289 0.6299 0.266
76

EMX2OS

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-339-5p;hsa-miR-33a-3p;hsa-miR-452-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 16 BDNF Sponge network 1.057 0.31716 0.503 0.16933 0.259
77

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-590-3p 13 PIK3CA Sponge network 1.057 0.31716 0.023 0.97942 0.254
78

HOTAIR

 hsa-miR-1275;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-592 12 EFNA5 Sponge network 1.894 0.10971 0.503 0.40444 0.25

Quest ID: e771520b0ec79e3850e1955e681015ee